JP2017137252A - Aqueous dispersion, cosmetic and method for producing the same - Google Patents
Aqueous dispersion, cosmetic and method for producing the same Download PDFInfo
- Publication number
- JP2017137252A JP2017137252A JP2016018327A JP2016018327A JP2017137252A JP 2017137252 A JP2017137252 A JP 2017137252A JP 2016018327 A JP2016018327 A JP 2016018327A JP 2016018327 A JP2016018327 A JP 2016018327A JP 2017137252 A JP2017137252 A JP 2017137252A
- Authority
- JP
- Japan
- Prior art keywords
- aqueous dispersion
- water
- weight
- cosmetic
- inorganic powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006185 dispersion Substances 0.000 title claims abstract description 94
- 239000002537 cosmetic Substances 0.000 title claims description 51
- 238000004519 manufacturing process Methods 0.000 title claims description 24
- 239000000843 powder Substances 0.000 claims abstract description 62
- 239000005871 repellent Substances 0.000 claims abstract description 38
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 33
- 238000004381 surface treatment Methods 0.000 claims abstract description 24
- 229920002683 Glycosaminoglycan Polymers 0.000 claims abstract description 20
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 64
- 239000002562 thickening agent Substances 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 19
- 229920006318 anionic polymer Polymers 0.000 claims description 15
- 230000002940 repellent Effects 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 8
- 229920002674 hyaluronan Polymers 0.000 claims description 8
- 229960003160 hyaluronic acid Drugs 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 6
- 239000008406 cosmetic ingredient Substances 0.000 claims description 5
- 159000000000 sodium salts Chemical class 0.000 claims description 5
- 238000010586 diagram Methods 0.000 abstract 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 63
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 43
- -1 methyl hydrogen Chemical compound 0.000 description 42
- 239000002245 particle Substances 0.000 description 40
- 239000000284 extract Substances 0.000 description 39
- 239000000203 mixture Substances 0.000 description 39
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 33
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 32
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 32
- 239000011787 zinc oxide Substances 0.000 description 30
- 235000014113 dietary fatty acids Nutrition 0.000 description 26
- 239000000194 fatty acid Substances 0.000 description 26
- 229930195729 fatty acid Natural products 0.000 description 26
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 23
- 239000007864 aqueous solution Substances 0.000 description 21
- 239000003795 chemical substances by application Substances 0.000 description 17
- 239000010419 fine particle Substances 0.000 description 17
- 239000000377 silicon dioxide Substances 0.000 description 16
- 229920002385 Sodium hyaluronate Polymers 0.000 description 14
- 229920001296 polysiloxane Polymers 0.000 description 14
- 229940010747 sodium hyaluronate Drugs 0.000 description 14
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 239000004359 castor oil Substances 0.000 description 13
- 235000019438 castor oil Nutrition 0.000 description 13
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 13
- 230000002776 aggregation Effects 0.000 description 12
- 239000003755 preservative agent Substances 0.000 description 12
- 229940058015 1,3-butylene glycol Drugs 0.000 description 11
- 229920002125 Sokalan® Polymers 0.000 description 11
- 235000019437 butane-1,3-diol Nutrition 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 11
- 238000004220 aggregation Methods 0.000 description 10
- 229920001577 copolymer Polymers 0.000 description 10
- 229940061571 peg-9 dimethicone Drugs 0.000 description 10
- 150000004665 fatty acids Chemical class 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- 230000002335 preservative effect Effects 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 7
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 7
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 description 7
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 7
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000004166 Lanolin Substances 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 229940008099 dimethicone Drugs 0.000 description 5
- 239000010954 inorganic particle Substances 0.000 description 5
- 235000019388 lanolin Nutrition 0.000 description 5
- 229940039717 lanolin Drugs 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- DSSYKIVIOFKYAU-OIBJUYFYSA-N (S)-camphor Chemical compound C1C[C@]2(C)C(=O)C[C@H]1C2(C)C DSSYKIVIOFKYAU-OIBJUYFYSA-N 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- WSWYZRBSUBMICN-UHFFFAOYSA-N azanium;2-(dimethylamino)-3-oxopent-4-ene-1-sulfonate Chemical compound [NH4+].[O-]S(=O)(=O)CC(N(C)C)C(=O)C=C WSWYZRBSUBMICN-UHFFFAOYSA-N 0.000 description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000012756 surface treatment agent Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 150000005215 alkyl ethers Chemical class 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229940092738 beeswax Drugs 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229910000420 cerium oxide Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 229920000058 polyacrylate Polymers 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 2
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 239000008385 outer phase Substances 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000011164 primary particle Substances 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 229940012831 stearyl alcohol Drugs 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- CWLGEPSKQDNHIO-JOBJLJCHSA-N (e)-n-[(e)-benzylideneamino]-1-phenylmethanimine Chemical compound C=1C=CC=CC=1/C=N/N=C/C1=CC=CC=C1 CWLGEPSKQDNHIO-JOBJLJCHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- DXMNMEWATKSWOT-UHFFFAOYSA-N 1-[2,3-di(nonyl)phenoxy]-2,3-di(nonyl)benzene Chemical compound CCCCCCCCCC1=CC=CC(OC=2C(=C(CCCCCCCCC)C=CC=2)CCCCCCCCC)=C1CCCCCCCCC DXMNMEWATKSWOT-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- ZXNAIPHYBVMMPY-KTKRTIGZSA-N 1-erucoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCC(O)CO ZXNAIPHYBVMMPY-KTKRTIGZSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- JWKSQNWLEIABLH-UHFFFAOYSA-N 1-octan-2-yloxydodecane Chemical compound CCCCCCCCCCCCOC(C)CCCCCC JWKSQNWLEIABLH-UHFFFAOYSA-N 0.000 description 1
- QQXJNLYVPPBERR-UHFFFAOYSA-N 1-phenyldecan-1-one Chemical compound CCCCCCCCCC(=O)C1=CC=CC=C1 QQXJNLYVPPBERR-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- ZUACFBHNVKYJFQ-UHFFFAOYSA-N 2-tert-butyl-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)C(=O)C1=CC=CC=C1 ZUACFBHNVKYJFQ-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- JOKBLKCZHGIRNO-UHFFFAOYSA-N 5-benzoyl-2-hydroxybenzoic acid Chemical compound C1=C(O)C(C(=O)O)=CC(C(=O)C=2C=CC=CC=2)=C1 JOKBLKCZHGIRNO-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 241000975394 Evechinus chloroticus Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- KILYNHHCRKVDRU-UHFFFAOYSA-N [S].C1CC2(C)C(=O)CC1C2(C)C Chemical compound [S].C1CC2(C)C(=O)CC1C2(C)C KILYNHHCRKVDRU-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 150000001343 alkyl silanes Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- FGEUKKGODAGXOD-FMIVXFBMSA-N cyclohexyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound C1=CC(OC)=CC=C1\C=C\C(=O)OC1CCCCC1 FGEUKKGODAGXOD-FMIVXFBMSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 1
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- KCDAMWRCUXGACP-DHZHZOJOSA-N ethyl (e)-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C\C1=CC=CC=C1 KCDAMWRCUXGACP-DHZHZOJOSA-N 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000005003 food packaging material Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- YKWKFUUHPFWRNV-UHFFFAOYSA-N methyl 3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(C(C)C)C=C1C(C)C YKWKFUUHPFWRNV-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- UVPGECJLXBGLDW-UHFFFAOYSA-N octadecan-7-ol Chemical compound CCCCCCCCCCCC(O)CCCCCC UVPGECJLXBGLDW-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- MSRJTTSHWYDFIU-UHFFFAOYSA-N octyltriethoxysilane Chemical compound CCCCCCCC[Si](OCC)(OCC)OCC MSRJTTSHWYDFIU-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- ZBVQEUUTPTVMHY-UHFFFAOYSA-N phenyl-(2-phenylphenyl)methanone Chemical compound C=1C=CC=C(C=2C=CC=CC=2)C=1C(=O)C1=CC=CC=C1 ZBVQEUUTPTVMHY-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 229940081510 piroctone olamine Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920003216 poly(methylphenylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001819 propan-2-yl (E)-3-phenylprop-2-enoate Substances 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- VZKNAUXVJXVEAG-UHFFFAOYSA-N propan-2-yl hexadecanoate;propan-2-yl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C.CCCCCCCCCCCCCCCC(=O)OC(C)C VZKNAUXVJXVEAG-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- WZXKPNYMUZGZIA-RMKNXTFCSA-N propyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCOC(=O)\C=C\C1=CC=C(OC)C=C1 WZXKPNYMUZGZIA-RMKNXTFCSA-N 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940043131 pyroglutamate Drugs 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 229920003179 starch-based polymer Polymers 0.000 description 1
- 239000004628 starch-based polymer Substances 0.000 description 1
- 229940100459 steareth-20 Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
- KWXLCDNSEHTOCB-UHFFFAOYSA-J tetrasodium;1,1-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)(C)P([O-])([O-])=O KWXLCDNSEHTOCB-UHFFFAOYSA-J 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical class CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- SVETUDAIEHYIKZ-IUPFWZBJSA-N tris[(z)-octadec-9-enyl] phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCCOP(=O)(OCCCCCCCC\C=C/CCCCCCCC)OCCCCCCCC\C=C/CCCCCCCC SVETUDAIEHYIKZ-IUPFWZBJSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
【課題】撥水性有機表面処理をされた無機粉体が安定に配合された水系分散体を得る。【解決手段】撥水性有機表面処理をされた無機粉体(A)、非イオン性界面活性剤(B)、多価アルコール(C)、及び、ムコ多糖(D)を含む水系分散体。【選択図】なしPROBLEM TO BE SOLVED: To obtain an aqueous dispersion in which an inorganic powder having a water-repellent organic surface treatment is stably blended. An aqueous dispersion containing a water-repellent organic surface-treated inorganic powder (A), a nonionic surfactant (B), a polyhydric alcohol (C), and a mucopolysaccharide (D). [Selection diagram] None
Description
本発明は、水系分散体、化粧料及びその製造方法に関するものである。 The present invention relates to an aqueous dispersion, a cosmetic, and a method for producing the same.
無機粉体、例えば数10〜100nmの粒子径を持つ微粒子酸化亜鉛や酸化チタンなどは、その特性から日焼け止め化粧料や屋外用インキ、食品包装材料などに添加剤等として多く使用されている。これらの粉体は未処理の状態であると、表面が親水性であるために汗や雨などで流れてしまうおそれがある。このため、特に化粧品などの用途ではシリコーンや金属石鹸などで粒子表面に撥水処理をして利用することが多い。 Inorganic powders such as fine particles of zinc oxide and titanium oxide having a particle size of several tens to 100 nm are often used as additives in sunscreen cosmetics, outdoor inks, food packaging materials and the like because of their characteristics. If these powders are in an untreated state, they may flow due to sweat or rain because the surface is hydrophilic. For this reason, in particular in applications such as cosmetics, the surface of the particles is often subjected to water repellent treatment with silicone or metal soap.
一方、一般に無機粉体は一次粒子が凝集しやすいために、微粒子酸化亜鉛や微粒子酸化チタンの可視光透明性や紫外線遮蔽性を充分に引き出す目的で、これらを分散媒中に分散させて使用することが広く行なわれている(特許文献1、2)。しかしながら、従来の分散体では、通常撥水性粉体は油に、親水性粉体は水やアルコール、グリコールなどに分散させていた。 On the other hand, since inorganic particles generally tend to agglomerate primary particles, they are used by dispersing them in a dispersion medium for the purpose of fully extracting visible light transparency and ultraviolet shielding properties of fine particle zinc oxide and fine particle titanium oxide. Is widely performed (Patent Documents 1 and 2). However, in the conventional dispersion, the water repellent powder is usually dispersed in oil, and the hydrophilic powder is dispersed in water, alcohol, glycol or the like.
近年は、みずみずしい感触で使用感に優れたO/W型乳化化粧料が好まれる傾向にあるため、撥水処理を施した上述の無機粉体を水相に添加する技術が検討されている。例えば、特許文献3では、分散剤を含有することで良好に撥水性処理を施した無機粒子を水性媒体中に均一に分散させた分散体が示されている。このような分散体を配合することでO/W系乳化型である日焼け止め剤を処方することも可能である。 In recent years, since there is a tendency to prefer O / W type emulsified cosmetics that have a fresh feel and excellent usability, a technique for adding the above-described inorganic powder subjected to water repellent treatment to an aqueous phase has been studied. For example, Patent Document 3 discloses a dispersion in which inorganic particles that have been well subjected to water repellency treatment by containing a dispersant are uniformly dispersed in an aqueous medium. It is also possible to formulate an O / W emulsion type sunscreen agent by blending such a dispersion.
なかでも、ジェルタイプと呼ばれる水が多く配合される剤型では、粘性を高める目的で種々の高分子増粘剤が使用されており、特に、アニオン性基の電荷反発により増粘するアニオン性高分子は、非曳糸性でみずみずしい感触に優れており、効果的に増粘できることから好適に汎用されている。 In particular, in the dosage form called gel type, which contains a lot of water, various polymer thickeners are used for the purpose of increasing the viscosity, and in particular, the anionic high viscosity increases due to charge repulsion of anionic groups. Molecules are suitable for general use because they are non-thready and have a fresh feel and can effectively thicken.
しかしながら、上述したような微粒子無機粉体は、アニオン性高分子と反応して粘性低下や凝集などを引き起こし、その結果、化粧料全体の安定性を低下させることが知られている。このため、撥水性無機粉体とアニオン性高分子増粘剤とを併用した際にも、粘度低下や凝集等の問題を引き起こしにくい水系化粧料の開発が望まれていた。 However, it is known that the fine particle inorganic powder as described above reacts with an anionic polymer to cause a decrease in viscosity, aggregation, and the like, and as a result, decreases the stability of the entire cosmetic. For this reason, even when the water repellent inorganic powder and the anionic polymer thickener are used in combination, there has been a demand for the development of a water-based cosmetic that hardly causes problems such as viscosity reduction and aggregation.
本発明の目的は、撥水性有機表面処理をされた無機粉体が安定に配合され、化粧料への配合時に、アニオン性高分子増粘剤と併用しても、化粧料自体の安定性に影響を及ぼさない水系分散体を得ることである。この水系分散体は、分散媒が水であるために、これを使用して得られた化粧料は使用感に優れ、さらに、無機粒子の分散状態が良好であるため、可視光透明性や紫外線遮蔽性を充分に引き出すことができるものである。 The object of the present invention is to stably mix inorganic powders having a water repellent organic surface treatment, and improve the stability of the cosmetic itself even when combined with an anionic polymer thickener when blended into the cosmetic. It is to obtain an aqueous dispersion that has no effect. In this aqueous dispersion, since the dispersion medium is water, the cosmetic obtained by using this is excellent in the feeling of use, and furthermore, since the dispersion state of the inorganic particles is good, visible light transparency and ultraviolet light The shielding property can be sufficiently extracted.
本発明は、撥水性有機表面処理をされた無機粉体(A)、非イオン性界面活性剤(B)、多価アルコール(C)、及び、ムコ多糖(D)を含むことを特徴とする水系分散体である。
上記ムコ多糖(D)は、撥水性有機表面処理をされた無機粉体(A)100重量部に対して0.01〜10重量部配合されていることが好ましい。
The present invention comprises an inorganic powder (A) that has been subjected to a water-repellent organic surface treatment, a nonionic surfactant (B), a polyhydric alcohol (C), and a mucopolysaccharide (D). It is an aqueous dispersion.
The mucopolysaccharide (D) is preferably blended in an amount of 0.01 to 10 parts by weight with respect to 100 parts by weight of the inorganic powder (A) subjected to the water repellent organic surface treatment.
上記ムコ多糖(D)は、ヒアルロン酸及び/又はそのナトリウム塩であることが好ましい。
本発明は、無機粉体(A)、非イオン性界面活性剤(B)、多価アルコール(C)と水を混合する工程(1)、さらにムコ多糖(D)を混合する工程(2)を含む上述した水系分散体の製造方法でもある。
The mucopolysaccharide (D) is preferably hyaluronic acid and / or a sodium salt thereof.
The present invention includes an inorganic powder (A), a nonionic surfactant (B), a step of mixing a polyhydric alcohol (C) and water (1), and a step of mixing a mucopolysaccharide (D) (2). It is also the manufacturing method of the aqueous dispersion containing the above-mentioned.
また、本発明は、上記水系分散体とアニオン性高分子増粘剤(E)を含むその他の化粧料成分を混合する工程(3)を含む製造方法により得られることを特徴とする化粧料でもある。
さらに、本発明は上記水系分散体と、アニオン性高分子増粘剤(E)を含むその他の化粧料成分を混合する工程(3)を含む化粧料の製造方法でもある。
上記化粧料は、水中油型乳化化粧料であることが好ましい。
The present invention also provides a cosmetic obtained by the production method including the step (3) of mixing the aqueous dispersion and other cosmetic ingredients including the anionic polymer thickener (E). is there.
Furthermore, this invention is also a manufacturing method of the cosmetics containing the process (3) which mixes the said aqueous dispersion and the other cosmetic ingredients containing anionic polymer thickener (E).
The cosmetic is preferably an oil-in-water emulsified cosmetic.
本発明の水系分散体は、撥水性有機表面処理をされた無機粉体(A)、非イオン性界面活性剤(B)、多価アルコール(C)、及び、ムコ多糖(D)を含むものであり、このような組成によって撥水性有機表面処理をされた無機粉体(A)を安定して保存・運搬等することができ、更に、化粧料を安定して製造することができる。このような水系分散体を使用した化粧料を得る場合、アニオン性高分子増粘剤と併用することが可能であり、この場合にも粘度低下や凝集等の安定性の低下が生じにくく、安定な化粧料を提供することができる。 The aqueous dispersion of the present invention comprises a water-repellent organic surface-treated inorganic powder (A), a nonionic surfactant (B), a polyhydric alcohol (C), and a mucopolysaccharide (D). Thus, the inorganic powder (A) subjected to the water-repellent organic surface treatment with such a composition can be stably stored and transported, and furthermore, a cosmetic can be stably produced. When obtaining a cosmetic using such an aqueous dispersion, it can be used in combination with an anionic polymer thickener, and in this case as well, stability reduction such as viscosity reduction and aggregation is unlikely to occur, and stable Cosmetics can be provided.
本発明の水系分散体は、撥水性有機表面処理をされた無機粉体(A)、非イオン性界面活性剤(B)、多価アルコール(C)、及び、ムコ多糖(D)を含むことを特徴とする水系分散体である。非イオン性界面活性剤(B)、多価アルコール(C)に加えて、更に、ムコ多糖(D)を併用することによって、撥水性有機表面処理をされた無機粉体(A)を水系媒体中により安定的に分散させることができるものである。 The aqueous dispersion of the present invention contains a water-repellent organic surface-treated inorganic powder (A), a nonionic surfactant (B), a polyhydric alcohol (C), and a mucopolysaccharide (D). Is an aqueous dispersion characterized by In addition to the nonionic surfactant (B) and the polyhydric alcohol (C), the inorganic powder (A) subjected to the water-repellent organic surface treatment by using the mucopolysaccharide (D) in combination with the aqueous medium It can be dispersed more stably inside.
本発明の水系分散体は、非イオン性界面活性剤(B)が撥水性有機表面処理された無機粉体(A)の撥水性処理された表面になじむことで水相での分散性が高まり、更にその表面にムコ多糖(D)が付着することで保護コロイドとしての作用がより好適に発現されると推測される。すなわち、(A)〜(D)の各成分が比較的高い濃度で一旦混合されることとなることで、ムコ多糖(D)による保護コロイド作用を容易に得ることができる。 The aqueous dispersion of the present invention has improved dispersibility in the aqueous phase by adapting the nonionic surfactant (B) to the water-repellent treated surface of the inorganic powder (A) treated with the water-repellent organic surface. Furthermore, it is presumed that the action as a protective colloid is more suitably expressed when mucopolysaccharide (D) adheres to the surface. That is, since the components (A) to (D) are once mixed at a relatively high concentration, the protective colloid action by the mucopolysaccharide (D) can be easily obtained.
また、撥水性有機表面処理された無機粉体(A)を保管・運搬等をする際に、上記(A)〜(D)を含有する水系分散体の状態として、当該水系分散体を化粧品原料として取引を行うことも好ましい。すなわち、上記水系分散体は、優れた安定性を有するものであることから、撥水性有機表面処理された無機粉体(A)において凝集・沈降等を生じずに保管するための形態としても望ましいものである。 Further, when the inorganic powder (A) treated with water-repellent organic surface is stored and transported, the aqueous dispersion is used as a cosmetic raw material in the state of the aqueous dispersion containing the above (A) to (D). It is also preferable to conduct a transaction as That is, since the aqueous dispersion has excellent stability, it is desirable as a form for storing the inorganic powder (A) subjected to the water repellent organic surface treatment without causing aggregation or sedimentation. Is.
上記撥水性有機表面処理をされた無機粉体(A)の基材粒子となる無機粉体としては限定されず、酸化亜鉛、酸化チタン、酸化セリウム、酸化鉄、硫酸バリウム、炭酸カルシウム、シリカ、水酸化アルミニウム、アルミナ、窒化硼素、タルク、マイカ、カオリン等を挙げることができる。上記無機粉体としては、酸化チタン、酸化亜鉛、酸化鉄、酸化セリウム及びこれらの複合体等の紫外線吸収・散乱能を有する無機粉体が特に好ましい。上記複合体は、表面処理粉体、無機粉体内部に他の無機粒子が分散した粉体などを指すものである。
紫外線遮蔽効果を有する無機粉体は、化粧料用途において汎用されるものであることから、水系の化粧料への配合が容易になる点でも好ましい。なかでも、特に酸化亜鉛、酸化チタンが好ましい。
これらの無機粉体は、2種以上の無機粉体を併用して使用するものであってもよい。
The inorganic powder used as the base particles of the inorganic powder (A) subjected to the water-repellent organic surface treatment is not limited, and zinc oxide, titanium oxide, cerium oxide, iron oxide, barium sulfate, calcium carbonate, silica, Examples include aluminum hydroxide, alumina, boron nitride, talc, mica, kaolin and the like. As the inorganic powder, an inorganic powder having ultraviolet absorption / scattering ability such as titanium oxide, zinc oxide, iron oxide, cerium oxide and a composite thereof is particularly preferable. The composite refers to a surface-treated powder, a powder in which other inorganic particles are dispersed inside an inorganic powder, and the like.
Since the inorganic powder having an ultraviolet shielding effect is widely used in cosmetic applications, it is also preferable in terms of easy blending into water-based cosmetics. Of these, zinc oxide and titanium oxide are particularly preferable.
These inorganic powders may be used in combination of two or more kinds of inorganic powders.
上記基材粒子となる無機粉体は、その表面をその他の無機材料で被覆した複合粉体であっても良い。その場合の表面処理材料は公知の無機表面処理材料で良いが、例えば酸化亜鉛、酸化チタン、酸化セリウム、酸化鉄、硫酸バリウム、含水ケイ酸、シリカ、水酸化アルミニウム、アルミナなどが挙げられる。その被覆量は無機粉体全体に対して、1重量%から30重量%が好ましい。 The inorganic powder serving as the substrate particles may be a composite powder whose surface is coated with another inorganic material. The surface treatment material in that case may be a known inorganic surface treatment material, and examples thereof include zinc oxide, titanium oxide, cerium oxide, iron oxide, barium sulfate, hydrous silicic acid, silica, aluminum hydroxide, and alumina. The coating amount is preferably 1% by weight to 30% by weight with respect to the whole inorganic powder.
上記基材粒子となる無機粉体が紫外線遮蔽粒子である場合は、平均粒子径が10〜200nmのものであることが好ましい。このような粒子径を有する紫外線遮蔽性粒子は、可視光透明性が高く、かつ、紫外線遮蔽領域が好適なものである点で特に好ましい。また、粒子径が200nmを超えると、可視光透明性が悪くなるだけでなく紫外線遮蔽能も低下するおそれがある。更に、粒子径が10nm未満であると、紫外線遮蔽能が低下するおそれがあるという点で好ましくない。また、上記無機粉体が紫外線遮蔽粒子でない場合や紫外線遮蔽性を必要としない場合は、粒子径はその粒子を利用するに最適な大きさであれば良い。なお、上記無機粉体の粒子径は、電子顕微鏡でランダムに選択した200個の粒子の粒子径を測定し、その一次粒子径の平均を算出するという方法によって測定されたものである。 When the inorganic powder serving as the base particle is an ultraviolet shielding particle, the average particle size is preferably 10 to 200 nm. Ultraviolet shielding particles having such a particle diameter are particularly preferred in that they have high visible light transparency and a suitable ultraviolet shielding region. On the other hand, when the particle diameter exceeds 200 nm, not only the visible light transparency is deteriorated, but also the ultraviolet shielding ability may be lowered. Furthermore, it is not preferable that the particle diameter is less than 10 nm in that the ultraviolet shielding ability may be lowered. Further, when the inorganic powder is not an ultraviolet shielding particle or does not require ultraviolet shielding properties, the particle diameter may be an optimum size for using the particle. The particle size of the inorganic powder was measured by a method of measuring the particle size of 200 particles randomly selected with an electron microscope and calculating the average of the primary particle sizes.
上記基材粒子となる無機粉体の形状は特に限定されず、球状、棒状、針状、紡錘状、板状等の任意の形状のものを使用することができる。なお、棒状、針状、紡錘状粒子の場合は上記平均粒子径は短軸側の長さを、板状の場合は面の対角線長さの平均で規定する。 The shape of the inorganic powder serving as the substrate particles is not particularly limited, and any shape such as a spherical shape, a rod shape, a needle shape, a spindle shape, or a plate shape can be used. In the case of rod-like, needle-like, and spindle-like particles, the average particle diameter is defined by the length on the short axis side, and in the case of a plate-like particle, the average of the diagonal lengths of the surfaces is defined.
上記撥水性有機表面処理をされた無機粉体(A)における撥水性有機表面処理の種類としては、特に限定されるものではなく、公知の表面処理を行うことができる。撥水性有機表面処理は、無機粉体表面の水との親和性を低下させる処理であり、処理を施した後において水に溶解しやすい材料、もしくは水に分散する材料による表面処理は本発明の「撥水性処理」には該当しない。 The kind of the water repellent organic surface treatment in the inorganic powder (A) subjected to the water repellent organic surface treatment is not particularly limited, and a known surface treatment can be performed. The water-repellent organic surface treatment is a treatment for reducing the affinity of the inorganic powder surface with water, and the surface treatment with a material that is easily dissolved in water or a material that is dispersed in water after the treatment is performed according to the present invention. Does not fall under “Water-repellent treatment”.
上記撥水性有機表面処理としては、より具体的には、例えば、メチルハイドロジェンポリシロキサン、ジメチルポリシロキサン、アルキルシラン、アルキルチタネート、金属石鹸、アミノ酸等による処理が挙げられる。 More specifically, examples of the water-repellent organic surface treatment include treatment with methyl hydrogen polysiloxane, dimethyl polysiloxane, alkylsilane, alkyl titanate, metal soap, amino acid, and the like.
上記撥水性有機表面処理は、シリコーン、シラン系処理剤、チタネート系処理剤等の反応性表面処理剤による処理が好ましい。表面処理剤として反応性のものを使用すると、表面処理剤が無機粉体から遊離しないという点で特に好ましい。上記表面処理剤が遊離してしまうと、無機粉体の凝集などが生じるため好ましくない。 The water repellent organic surface treatment is preferably a treatment with a reactive surface treatment agent such as silicone, silane treatment agent, titanate treatment agent or the like. The use of a reactive agent as the surface treatment agent is particularly preferable in that the surface treatment agent is not released from the inorganic powder. If the surface treatment agent is liberated, it is not preferable because aggregation of inorganic powder occurs.
上記シリコーンとしては、ジメチルポリシロキサン、メチルハイドロジェンポリシロキサン、(ジメチコン/メチコン)コポリマー等の水素−ケイ素結合を有する公知のシリコーン等を挙げることができる。また、反応基としてアルコキシ基−ケイ素結合を有する、トリエトキシシリルエチルポリジメチルシロキシエチルジメチコン(信越化学工業製KF−9908)、トリエトキシシリルエチルポリジメチルシロキシエチルヘキシルジメチコン(信越化学工業製KF−9909)なども挙げることができる。
上記シラン系処理剤としては、有機基を導入したシリル化剤、シランカップリング剤を挙げることができ、例えば、トリエトキシカプリリルシランを挙げることができる。
上記チタネート系処理剤としては、アルキルチタネート、ピロリン酸型のチタネート、亜リン酸型のチタネート、アミノ酸型のチタネート、のチタンカップリング剤等を挙げることができる。より具体的には、例えば、チタンイソステアレート(マツモトファインケミカル株式会社製、オルガチックスTC−800)が挙げられる。
Examples of the silicone include known silicones having a hydrogen-silicon bond, such as dimethylpolysiloxane, methylhydrogenpolysiloxane, and (dimethicone / methicone) copolymer. Also, triethoxysilylethyl polydimethylsiloxyethyl dimethicone (KF-9908 manufactured by Shin-Etsu Chemical Co., Ltd.), triethoxysilylethyl polydimethylsiloxyethylhexyl dimethicone (KF-9909 manufactured by Shin-Etsu Chemical Co., Ltd.) having an alkoxy group-silicon bond as a reactive group. And so on.
Examples of the silane-based treatment agent include a silylating agent and a silane coupling agent into which an organic group is introduced, and examples thereof include triethoxycaprylylsilane.
Examples of the titanate treatment agents include alkyl titanates, pyrophosphoric acid type titanates, phosphorous acid type titanates, amino acid type titanates, and titanium coupling agents. More specifically, for example, titanium isostearate (manufactured by Matsumoto Fine Chemical Co., Ltd., ORGATICS TC-800) can be mentioned.
上記無機粉体の撥水性有機処理においては、処理後の無機粉体の全量に対して、2〜12重量%の割合で上記処理剤による撥水性有機処理が施されたものであることが好ましい。2重量%未満であると、撥水性が不十分であるという点で好ましくなく、12重量%を超えると、撥水性の効果が飽和しコストのみが上昇したり、感触が悪化するという点で好ましくない。上記撥水処理は、3〜10重量%の割合で上記撥水処理が施されたものであることがより好ましい。 In the water-repellent organic treatment of the inorganic powder, the water-repellent organic treatment with the treatment agent is preferably performed at a ratio of 2 to 12% by weight with respect to the total amount of the inorganic powder after the treatment. . If it is less than 2% by weight, it is not preferable from the viewpoint that the water repellency is insufficient, and if it exceeds 12% by weight, the effect of water repellency is saturated and only the cost is increased or the touch is deteriorated. Absent. The water-repellent treatment is more preferably performed at a ratio of 3 to 10% by weight.
上記撥水性有機表面処理をされた無機粉体(A)は、水系分散体中に10〜70重量%の割合で含まれることが好ましい、10重量%未満であると、粉体濃度が低すぎて配合する分散体量を増やす必要があるという点で好ましくなく、70重量%を超えると分散体の粘度が高すぎて流動性を失い、配合しづらくなるという点で好ましくない。上記上限は、60重量%であることがより好ましい。上記下限は、15重量%であることがより好ましく、20重量%であることが更に好ましい。 The water-repellent organic surface-treated inorganic powder (A) is preferably contained in the aqueous dispersion at a ratio of 10 to 70% by weight. If it is less than 10% by weight, the powder concentration is too low. It is not preferable in that it is necessary to increase the amount of the dispersion to be blended, and if it exceeds 70% by weight, the viscosity of the dispersion is too high and the fluidity is lost, so that it is difficult to blend. The upper limit is more preferably 60% by weight. The lower limit is more preferably 15% by weight and even more preferably 20% by weight.
本発明の水系分散体は、非イオン性界面活性剤(B)を含有するものである。これによって、良好に撥水性処理を施した無機粒子を水性媒体中に均一に分散させることができる。
非イオン性界面活性剤の種類としては、ポリオキシアルキレンアルキルエーテル、ポリオキシアルキレン脂肪酸エステル、ポリオキシアルキレンソルビタン脂肪酸エステル、ポリオキシアルキレンヒマシ油、ポリオキシアルキレン硬化ヒマシ油、ポリオキシアルキレンソルビトールテトラ脂肪酸エステル、グリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ショ糖脂肪酸エステル、ポリオキシアルキレン基を有するオルガノポリシロキサン、ポリグリセリン基を有するオルガノポリシロキサン、糖鎖を有するオルガノポリシロキサン等が挙げられる。
The aqueous dispersion of the present invention contains a nonionic surfactant (B). This makes it possible to uniformly disperse the inorganic particles that have been satisfactorily water repellent treated in the aqueous medium.
Nonionic surfactants include polyoxyalkylene alkyl ether, polyoxyalkylene fatty acid ester, polyoxyalkylene sorbitan fatty acid ester, polyoxyalkylene castor oil, polyoxyalkylene hydrogenated castor oil, polyoxyalkylene sorbitol tetra fatty acid ester. Glycerin fatty acid ester, sorbitan fatty acid ester, polyglycerin fatty acid ester, sucrose fatty acid ester, organopolysiloxane having a polyoxyalkylene group, organopolysiloxane having a polyglycerin group, organopolysiloxane having a sugar chain, and the like.
中でも、ポリオキシアルキレン脂肪酸エステル、ポリオキシアルキレンソルビタン脂肪酸エステル、ポリオキシアルキレン基を有するオルガノポリシロキサンを非イオン性界面活性剤として使用することが好ましい。 Among these, polyoxyalkylene fatty acid esters, polyoxyalkylene sorbitan fatty acid esters, and organopolysiloxanes having a polyoxyalkylene group are preferably used as nonionic surfactants.
また、上記非イオン性界面活性剤(B)は、1,3−ブチレングリコールに20重量%濃度で混合したとき、35℃において透明溶解又は微濁する非イオン性界面活性剤(非イオン性界面活性剤(B)が室温にてペースト状〜固体の場合は加温して均一にしたのち35℃にして確認)であることが好ましい。このような非イオン性界面活性剤を使用することで、粒子表面に効率的に非イオン性界面活性剤による層を作ることが出来るという効果が得られる。 The nonionic surfactant (B) is a nonionic surfactant (nonionic interface) that is transparently dissolved or slightly turbid at 35 ° C. when mixed with 1,3-butylene glycol at a concentration of 20% by weight. When the activator (B) is in the form of a paste or solid at room temperature, it is preferably heated and homogenized and then confirmed at 35 ° C.). By using such a nonionic surfactant, the effect that the layer by a nonionic surfactant can be efficiently made on the particle | grain surface is acquired.
なお、上記「透明溶解」とは、得られた混液の35℃における光路長10mmでのヘーズ値が10未満であることを意味し、「微濁」とは得られた混液の35℃における光路長10mmでのヘーズ値が10以上、且つ、全光透過率が30%以上である状態であることを意味する。 The “transparent dissolution” means that the obtained mixture has a haze value of less than 10 at an optical path length of 10 mm at 35 ° C., and “slightly turbid” means the optical path of the obtained mixture at 35 ° C. It means that the haze value at a length of 10 mm is 10 or more and the total light transmittance is 30% or more.
さらに、上記非イオン性界面活性剤(B)は、水に20重量%濃度で混合したとき、35℃において不溶又は白濁する非イオン性界面活性剤(非イオン性界面活性剤が室温にてペースト状〜固体の場合は加温して均一にしたのち35℃にして確認)であることが好ましい。なお、2種以上の非イオン性界面活性剤を組み合わせて使用する場合は、水系分散体中に配合する混合比で混合した非イオン性界面活性剤について、上述した試験を行った場合に不溶又は白濁することが必要である。 Furthermore, the nonionic surfactant (B) is a nonionic surfactant that is insoluble or cloudy at 35 ° C. when mixed in water at a concentration of 20% by weight (the nonionic surfactant is a paste at room temperature). In the case of a solid to a solid, it is preferably heated and homogenized and then confirmed at 35 ° C.). When two or more kinds of nonionic surfactants are used in combination, the nonionic surfactant mixed in the aqueous dispersion is insoluble when the above-described test is performed on the nonionic surfactant mixed. It is necessary to become cloudy.
なお、本明細書において「不溶」とは、混合させても溶け残りが生じたり、又は、一見混濁したように見えても1時間経過後には相分離してしまったりする状態を意味し、「白濁」とは得られた混液の35℃における光路長10mmでのヘーズ値が10以上、且つ、全光透過率が30%未満である状態であることを意味する。 In the present specification, “insoluble” means a state in which undissolved residue is produced even when mixed, or phase separation occurs after 1 hour even though it appears to be turbid. The term “white turbidity” means that the resulting mixture has a haze value of 10 or more at an optical path length of 10 mm at 35 ° C. and a total light transmittance of less than 30%.
また、非イオン性界面活性剤(B)のHLB値は10〜17であるものが好ましい。この範囲を外れると粉体の分散不良が起こり、紫外線遮蔽性などの各種物性に影響を与える場合がある。本発明ではW.C.Grifinnによって定義された次式によって求める。
NHLB=(E+P)/5
(NHLB:HLB値、E:ポリオキシエチレン部の非イオン性界面活性剤分子全体に対する重量%、P:多価アルコール部の非イオン性界面活性剤分子全体に対する重量%)
The nonionic surfactant (B) preferably has an HLB value of 10 to 17. Outside this range, poor dispersion of the powder occurs, which may affect various physical properties such as ultraviolet shielding properties. In the present invention, W.C. C. It is obtained by the following formula defined by Grifinn.
N HLB = (E + P) / 5
(N HLB : HLB value, E:% by weight of polyoxyethylene part with respect to the whole nonionic surfactant molecule, P:% by weight of polyhydric alcohol part with respect to the whole nonionic surfactant molecule)
上記非イオン性界面活性剤(B)は、水系分散体中に1〜10重量%の割合で含まれることが好ましい、1重量%未満であると、粉体が水になじむことが難しいという点で好ましくなく、10重量%を超えるとコスト的に不利であるという点で好ましくない。上記上限は、8重量%であることがより好ましい。上記下限は、1.5重量%であることがより好ましく、2重量%であることが更に好ましい。 The nonionic surfactant (B) is preferably contained in the aqueous dispersion at a ratio of 1 to 10% by weight, and if it is less than 1% by weight, it is difficult for the powder to be compatible with water. It is not preferable, and if it exceeds 10% by weight, it is not preferable in that it is disadvantageous in terms of cost. The upper limit is more preferably 8% by weight. The lower limit is more preferably 1.5% by weight, still more preferably 2% by weight.
本発明の水系分散体は、更に、多価アルコール(C)を含有するものである。上記多価アルコールとしては特に限定されないが、プロピレングリコール、ブチレングリコール、ジプロピレングリコール、ペンチレングリコール、へキシレングリコール等の多価アルコールを使用することが特に好ましい。これらの群のなかから2種以上の化合物を併用して使用してもよい。なかでも、ペンチレングリコール、1,3−ブチレングリコールを使用することが特に好ましい。上記多価アルコールは、水系分散体における撥水有機処理された無機粉体(A)の分散性を高めるだけではなく、抗菌性能を有することから防腐剤としての効果も有する。 The aqueous dispersion of the present invention further contains a polyhydric alcohol (C). Although it does not specifically limit as said polyhydric alcohol, It is especially preferable to use polyhydric alcohols, such as propylene glycol, butylene glycol, dipropylene glycol, pentylene glycol, and hexylene glycol. Two or more compounds from these groups may be used in combination. Of these, pentylene glycol and 1,3-butylene glycol are particularly preferably used. The polyhydric alcohol not only enhances the dispersibility of the water-repellent organic-treated inorganic powder (A) in the aqueous dispersion, but also has an effect as a preservative because it has antibacterial performance.
上記多価アルコール(C)は、水系分散体中に3〜10重量%の割合で含まれることが好ましい、3重量%未満であると、分散体の安定性が著しく悪くなるという点で好ましくなく、10重量%を超えると多価アルコールに由来して感触悪化しやすくなるという点で好ましくない。上記上限は、9重量%であることがより好ましい。上記下限は、3.2重量%であることがより好ましく、4重量%であることが更に好ましい。 The polyhydric alcohol (C) is preferably contained in the aqueous dispersion at a ratio of 3 to 10% by weight. If it is less than 3% by weight, it is not preferable in that the stability of the dispersion is remarkably deteriorated. If it exceeds 10% by weight, it is not preferable in that the feel is likely to deteriorate due to the polyhydric alcohol. The upper limit is more preferably 9% by weight. The lower limit is more preferably 3.2% by weight, still more preferably 4% by weight.
本発明の水系分散体は、更に、ムコ多糖(D)を含有するものである。上記ムコ多糖(D)は、撥水性有機表面処理をされた無機粉体(A)とともに水系分散体中に存在すると、保護コロイドとして作用することによって、撥水性有機表面処理をされた無機粉体(A)の系内での安定性を高める作用を有することが明らかとなった。更に、アニオン性高分子増粘剤と併用して水系分散体とした場合であっても、凝集・粘度上昇等による水系化粧料の劣化を抑制することができる。 The aqueous dispersion of the present invention further contains mucopolysaccharide (D). When the mucopolysaccharide (D) is present in the water-based dispersion together with the inorganic powder (A) having been subjected to the water-repellent organic surface treatment, the mucopolysaccharide (D) acts as a protective colloid so that the inorganic powder has been subjected to the water-repellent organic surface treatment. It became clear that it has the effect | action which improves the stability in the system of (A). Furthermore, even when the aqueous dispersion is used in combination with an anionic polymer thickener, it is possible to suppress deterioration of the aqueous cosmetic due to aggregation, viscosity increase, and the like.
上記ムコ多糖(D)としては特に限定されず、例えば、ヒアルロン酸及び/又はそのナトリウム塩、コンドロイチン硫酸及び/又はそのナトリウム塩等が挙げられ、なかでも、ヒアルロン酸及び/又はそのナトリウム塩であることが好ましい。具体的には、例えば、マツヒアロHA−P(マツモト交商製)、マツヒアロHA−BG(マツモト交商製)、マツヒアロHA−LP(マツモト交商製)が挙げられる。 The mucopolysaccharide (D) is not particularly limited, and examples thereof include hyaluronic acid and / or a sodium salt thereof, chondroitin sulfate and / or a sodium salt thereof, and in particular, hyaluronic acid and / or a sodium salt thereof. It is preferable. Specifically, for example, Matsuhiaro HA-P (manufactured by Matsumoto Kosho), Matsuhiaro HA-BG (manufactured by Matsumoto Kosho), Matsuhiaro HA-LP (manufactured by Matsumoto Kosho) can be mentioned.
上記ムコ多糖(D)は、水系分散体に0.001〜7重量%の割合で含まれることが好ましい。0.001重量%未満であると、増粘剤と併用した際に処方系の粘度を安定する効果が薄くなるという点で好ましくなく、7重量%を超えるとべたつき等の感触の悪化を引き起こすという点で好ましくない。上記上限は、3.5重量%であることがより好ましい。上記下限は、0.005重量%であることがより好ましい。 The mucopolysaccharide (D) is preferably contained in the aqueous dispersion in a proportion of 0.001 to 7% by weight. If it is less than 0.001% by weight, it is not preferable in that the effect of stabilizing the viscosity of the prescription system becomes thin when used in combination with a thickener, and if it exceeds 7% by weight, it may cause a deterioration in feel such as stickiness. It is not preferable in terms. The upper limit is more preferably 3.5% by weight. The lower limit is more preferably 0.005% by weight.
上記水系分散体は、ムコ多糖(D)を撥水性有機表面処理をされた無機粉体(A)100重量部に対して0.01〜10重量部の割合で含まれることが好ましい。0.01重量%未満であると、増粘剤と併用した際に処方系の粘度を安定する効果が薄くなるという点で好ましくなく、10重量%を超えるとべたつき等の感触の悪化を引き起こすという点で好ましくない。上記上限は、5重量%であることがより好ましい。上記下限は、0.05重量%であることがより好ましい。 The aqueous dispersion is preferably contained in an amount of 0.01 to 10 parts by weight with respect to 100 parts by weight of the inorganic powder (A) subjected to the water-repellent organic surface treatment for the mucopolysaccharide (D). When it is less than 0.01% by weight, it is not preferable in that the effect of stabilizing the viscosity of the prescription system becomes thin when used in combination with a thickener. It is not preferable in terms. The upper limit is more preferably 5% by weight. The lower limit is more preferably 0.05% by weight.
上記水系分散体は、水を水系分散体の全量に対して3〜85重量%の割合で含まれることが好ましい。3重量%未満であると、分散物が固形化し液状物でなくなることや、分散粒子が凝集しやすくなるという点で好ましくなく、85重量%を超えると微粒子無機粉体の配合量が相対的に減り処方自由度が減少するという点で好ましくない。上記上限は、80重量%であることがより好ましい。上記下限は、10重量%であることがより好ましい。 The aqueous dispersion preferably contains water in a proportion of 3 to 85% by weight with respect to the total amount of the aqueous dispersion. If it is less than 3% by weight, it is not preferable from the viewpoint that the dispersion is solidified and is not liquid, and the dispersed particles are likely to aggregate. It is not preferable in that it reduces the degree of freedom of prescription. The upper limit is more preferably 80% by weight. The lower limit is more preferably 10% by weight.
上記水系分散体は、更に、防腐剤を配合してもよい。すなわち、上記成分からなる分散体は、保管条件や保管期間によっては腐敗を生じることがある。このような腐敗を防止するため、防腐剤を添加してもよい。このような防腐剤としては特に限定されず、例えば、パラオキシ安息香酸メチル等のパラ安息香酸エステル、ピロクトンオラミン、フェノキシエタノール、カプリルサンポリグリセリル−3等を挙げることができる。これらは成分ごとに、防腐性能を発揮し、なおかつ、非イオン性界面活性剤の性能に悪影響を与えない範囲内で添加することができる。 The aqueous dispersion may further contain a preservative. That is, the dispersion composed of the above components may be spoiled depending on the storage conditions and storage period. In order to prevent such spoilage, a preservative may be added. Such a preservative is not particularly limited, and examples thereof include parabenzoic acid esters such as methyl paraoxybenzoate, piroctone olamine, phenoxyethanol, and capryl sun polyglyceryl-3. Each of these components can be added within a range that exhibits antiseptic performance and does not adversely affect the performance of the nonionic surfactant.
上記水系分散体に防腐剤を配合する場合、防腐剤を水系分散体の全量に対して20重量%以下の割合で配合することが好ましい。0.001重量%未満であると、抗菌効果が弱いという点で好ましくなく、15重量%を超えると肌への刺激性などの懸念が発生するという点で好ましくない。上記上限は、10重量%であることがより好ましく、5重量%であることが更に好ましい。 When a preservative is blended in the aqueous dispersion, the preservative is preferably blended at a ratio of 20% by weight or less with respect to the total amount of the aqueous dispersion. If it is less than 0.001% by weight, it is not preferable in that the antibacterial effect is weak, and if it exceeds 15% by weight, it is not preferable in that concerns such as irritation to the skin may occur. The upper limit is more preferably 10% by weight, and still more preferably 5% by weight.
上記水系分散体は、上述した成分(A)〜(D)、水及び防腐剤以外の成分の配合量が20重量%以下であることが好ましい。上述した以外の成分を多量に配合すると、水系分散体の安定性が損なわれる可能性が高いためである。上述した成分(A)〜(D)及び水以外の成分の配合量は、10重量%以下であることがより好ましく、5重量%以下であることが更に好ましい。 In the aqueous dispersion, the amount of components other than the above-described components (A) to (D), water and preservatives is preferably 20% by weight or less. This is because when the components other than those described above are blended in a large amount, the stability of the aqueous dispersion is likely to be impaired. The blending amount of the components (A) to (D) and the components other than water is more preferably 10% by weight or less, and further preferably 5% by weight or less.
本発明の水系分散体は、各成分(A)〜(D)、水、防腐剤以外の成分を含有しないものであることがもっとも好ましい。その他の成分を配合することによって、かえって安定性に悪影響を与えるおそれが生じるためである。また、化粧品に配合する場合に配合したくない成分が含まれるおそれがあることも好ましくないものである。 Most preferably, the aqueous dispersion of the present invention does not contain components other than the components (A) to (D), water, and preservatives. This is because mixing other components may adversely affect the stability. In addition, it is not preferable that components that are not desired to be blended may be included when blended into cosmetics.
なお、各成分(A)〜(D)、水、防腐剤として市販のものを使用した場合は、これらの市販原料が酸化防止剤、残存原料等の混在成分を若干量含有している場合がある。本明細書における「各成分(A)〜(D)、水、防腐剤以外の成分を含有しない」とは、このような原料由来の混在成分を0.1重量%以下の割合で含有する場合も包含するものである。例えば、市販の非イオン性界面活性剤においては、酸化防止剤(トコフェロール)が添加されているものがあるが、このような原料由来の酸化防止剤が組成物全量に対して0.1重量%の割合で含まれる場合は、「無機粉体、非イオン性界面活性剤、水及び防腐剤以外の成分を含有しないもの」に該当する。 In addition, when a commercially available thing is used as each component (A)-(D), water, and antiseptic | preservative, these commercially available raw materials may contain some amounts of mixed components, such as antioxidant and a residual raw material. is there. In this specification, “each component (A) to (D), water, no components other than preservatives” means that such a mixed component derived from raw materials is contained in a proportion of 0.1% by weight or less. Is also included. For example, in some commercially available nonionic surfactants, an antioxidant (tocopherol) is added, but the antioxidant derived from such a raw material is 0.1% by weight based on the total amount of the composition. In the case where it is contained at a ratio of 1, it corresponds to “a substance containing no components other than inorganic powder, nonionic surfactant, water and preservative”.
上述した水系分散体の製造方法としては、成分(A)〜(C)及び水を充分に混合する工程(1)によって水性分散体とした後、成分(D)を添加して更に混合する工程(2)によって分散体を調製することが好ましい。このような方法によって、ダマ等の発生を抑制し、各成分を高い均一性で混合することができ、成分(A)が均一に分散した水系分散体を得ることができる。成分(A)〜(D)を全て同時に混合した場合は、成分(A)が分散しなかったり、ダマが発生したりして、分散体を得ることができない。 As a manufacturing method of the aqueous dispersion mentioned above, after making it into an aqueous dispersion by the process (1) which fully mixes component (A)-(C) and water, the process of adding and further mixing a component (D) It is preferable to prepare a dispersion according to (2). By such a method, generation | occurrence | production of lumps etc. can be suppressed, each component can be mixed with high uniformity, and the aqueous dispersion with which component (A) was disperse | distributed uniformly can be obtained. When all of the components (A) to (D) are mixed at the same time, the component (A) is not dispersed or lumps are generated, and a dispersion cannot be obtained.
上述した成分(A)〜(D)を含有する水系分散体は、これを原料として使用して化粧料を得ることができる。本発明は、上記水系分散体をその他の化粧料成分と混合する工程(3)を含む化粧料の製造方法及び当該製造方法によって得られた化粧料でもある。 The aqueous dispersion containing the components (A) to (D) described above can be used as a raw material to obtain a cosmetic. This invention is also the cosmetics obtained by the manufacturing method of the cosmetics including the process (3) which mixes the said aqueous dispersion with another cosmetics ingredient, and the said manufacturing method.
上記化粧料は、水性化粧料、O/W型化粧料(すなわち、水中油型化粧料)、W/O型化粧料等、水相中に撥水性有機表面処理をされた無機粉体(A)が分散した態様であれば、任意の系とすることができる。
なかでも、O/W型の剤の場合、水の量が多く、水が外相にあるため、水系分散体の配合量を増やせること、外相に無機粉体が存在するため、使用時に無機粉体を均一に塗布することができ、特に紫外線遮蔽用途において、効率的に紫外線をカットすることができるという観点において特に好ましい。
本発明の化粧料において、撥水性有機表面処理をされた無機粉体(A)は、水相中に分散していることが好ましい。
Examples of the cosmetics include water-based cosmetics, O / W-type cosmetics (that is, oil-in-water cosmetics), W / O-type cosmetics, and the like, which are inorganic powders (A As long as the above is dispersed, any system can be used.
In particular, in the case of an O / W type agent, since the amount of water is large and water is in the outer phase, the amount of the aqueous dispersion can be increased, and the inorganic powder is present in the outer phase. Is particularly preferable from the viewpoint that ultraviolet rays can be efficiently cut, particularly in ultraviolet shielding applications.
In the cosmetic of the present invention, the inorganic powder (A) that has been subjected to the water-repellent organic surface treatment is preferably dispersed in the aqueous phase.
本発明の化粧料は、更に、アニオン性高分子増粘剤(E)を含むものであることが好ましい。上述したように、本発明は従来問題とされてきた撥水性有機表面処理をされた無機粉体(A)とアニオン性高分子増粘剤(E)とを併用した場合に生じる問題を改善できる、という効果を有するものである。すなわち、アニオン性高分子増粘剤(E)と併用した場合にも安定した増粘効果が得られる点で好ましい。 The cosmetic of the present invention preferably further contains an anionic polymer thickener (E). As described above, the present invention can improve the problems caused when the inorganic powder (A) subjected to the water-repellent organic surface treatment and the anionic polymer thickener (E) are used in combination. , Has the effect of. That is, it is preferable in that a stable thickening effect can be obtained even when used in combination with the anionic polymer thickener (E).
上記アニオン性高分子増粘剤としては特に限定されず、カルボキシビニルポリマー、アクリル酸・メタクリル酸アルキル共重合体、(アクリレーツ/イタコン酸ステアレス−20)コポリマー、アクリル酸アルキルコポリマー、(アクリル酸アルキル/メタクリル酸ステアレス−20)コポリマー、(アクリロイルジメチルタウリンアンモニウム/VP(ビニルピロリドン))コポリマー(例えば、クラリアント製「Aristoflex AVC」)、(アクリロイルジメチルタウリンアンモニウム/メタクリル酸ベヘネス−25)クロスポリマー(例えば、クラリアント製「Aristoflex HMB」)、ポリアクリレートクロスポリマー−11(例えば、クラリアント製「Aristoflex Velet」)などを挙げることができる。上記アニオン性高分子増粘剤は、1種を単独で用いてもよく、2種以上を併用してもよく、なかでも、カルボキシビニルポリマー、(アクリロイルジメチルタウリンアンモニウム/VP)コポリマーが好ましい。 The anionic polymer thickener is not particularly limited, and is a carboxyvinyl polymer, acrylic acid / alkyl methacrylate copolymer, (acrylates / italaconic acid steareth-20) copolymer, alkyl acrylate copolymer, (alkyl acrylate / Stearless methacrylate-20) copolymer, (acryloyldimethyltaurate ammonium / VP (vinyl pyrrolidone)) copolymer (eg “Aristoflex AVC” from Clariant), (acryloyldimethyltaurine ammonium / benheneth methacrylate-25) crosspolymer (eg, Clariant) "Aristoflex HMB"), polyacrylate crosspolymer-11 (for example, "Aristoflex Velet" manufactured by Clariant) It can be. The anionic polymer thickeners may be used alone or in combination of two or more. Among them, carboxyvinyl polymer and (acryloyldimethyltaurine ammonium / VP) copolymer are preferable.
上記アニオン性高分子増粘剤(E)は、化粧料中に0.001〜2重量%の割合で含まれることが好ましい。0.001重量%未満であると、増粘効果に乏しいという点で好ましくなく、2重量%を超えると塗布後に塗膜感が強く出て感触が悪くなるという点で好ましくない。上記上限は、1重量%であることがより好ましい。上記下限は、0.002重量%であることがより好ましく、0.05重量%であることが更に好ましい。 The anionic polymer thickener (E) is preferably contained in the cosmetic at a ratio of 0.001 to 2% by weight. If it is less than 0.001% by weight, it is not preferable from the viewpoint that the effect of thickening is poor, and if it exceeds 2% by weight, it is not preferable from the viewpoint that the coating feels strongly after application and the feel becomes poor. The upper limit is more preferably 1% by weight. The lower limit is more preferably 0.002% by weight, still more preferably 0.05% by weight.
上記水系分散体を使用した化粧料の製造方法及び化粧料において、上述した水系分散体を任意の化粧料成分と混合することができる。上記化粧料原料としては特に限定されず、例えば、油剤、界面活性剤、保湿剤、高級アルコール、金属イオン封鎖剤、天然及び合成高分子、水溶性及び油溶性高分子、紫外線遮蔽剤、各種抽出液、有機染料等の色剤、防腐剤、酸化防止剤、色素、増粘剤、pH調整剤、香料、冷感剤、制汗剤、殺菌剤、皮膚賦活剤、各種粉体等の成分を含有するものであってもよい。 In the cosmetic production method and cosmetic using the aqueous dispersion, the above-described aqueous dispersion can be mixed with any cosmetic ingredient. The cosmetic raw material is not particularly limited, and examples thereof include oil agents, surfactants, humectants, higher alcohols, sequestering agents, natural and synthetic polymers, water-soluble and oil-soluble polymers, ultraviolet screening agents, and various extractions. Components such as liquid, organic dyes, antiseptics, antioxidants, pigments, thickeners, pH adjusters, fragrances, cooling agents, antiperspirants, fungicides, skin activators, various powders, etc. It may be contained.
なお、上記水系分散体中に含まれる成分と同一の成分を上述したその他の化粧料成分と混合する工程において、更に添加するものであっても差し支えはない。但し、撥水性有機表面処理をされた無機粉体(A)については、安定性を損なうおそれがあることから、工程(3)において添加しないことが好ましい。 In addition, in the process which mixes the component same as the component contained in the said aqueous dispersion with the other cosmetics component mentioned above, it does not interfere even if it adds further. However, it is preferable not to add the inorganic powder (A) subjected to the water repellent organic surface treatment in the step (3) because there is a risk of impairing stability.
上記油剤は特に限定はないが、例えば、天然動植物油脂(例えば、オリーブ油、ミンク油、ヒマシ油、パーム油、牛脂、月見草油、ヤシ油、ヒマシ油、カカオ油、マカデミアナッツ油等);蝋(例えば、ホホバ油、ミツロウ、ラノリン、カルナウバロウ、キャンデリラロウ等);高級アルコール(例えば、ラウリルアルコール、ステアリルアルコール、セチルアルコール、オレイルアルコール等);高級脂肪酸(例えば、ラウリン酸、パルミチン酸、ステアリン酸、オレイン酸、ベヘニン酸、ラノリン脂肪酸等;高級脂肪族炭化水素例えば、流動パラフィン、固形パラフィン、スクワラン、ワセリン、セレシン、マイクロクリスタリンワックス等);合成エステル油(例えば、ブチルステアレート、ヘキシルラウレート、ジイソプロピルアジペート、ジイソプロピルセバケート、ミリスチン酸オクチルドデシル、イソプロピルミリステート、イソプロピルパルミテートイソプロピルミリステート、セチルイソオクタノエート、ジカプリン酸ネオペンチルグリコール);シリコーン誘導体(例えば、メチルシリコーン、メチルフェニルシリコーン等のシリコーン油)などが例示できる。さらに、油溶性のビタミン、防腐剤、美白剤などを配合することもできる。 The oil agent is not particularly limited. For example, natural animal and vegetable oils and fats (for example, olive oil, mink oil, castor oil, palm oil, beef tallow, evening primrose oil, coconut oil, castor oil, cacao oil, macadamia nut oil, etc.); wax (for example, Jojoba oil, beeswax, lanolin, carnauba wax, candelilla wax, etc.); higher alcohols (eg, lauryl alcohol, stearyl alcohol, cetyl alcohol, oleyl alcohol, etc.); higher fatty acids (eg, lauric acid, palmitic acid, stearic acid, olein) Acids, behenic acid, lanolin fatty acids, etc .; higher aliphatic hydrocarbons such as liquid paraffin, solid paraffin, squalane, petrolatum, ceresin, microcrystalline wax, etc .; synthetic ester oils (eg, butyl stearate, hexyl laurate, diisopropyl azimuth) , Diisopropyl sebacate, octyldodecyl myristate, isopropyl myristate, isopropyl palmitate isopropyl myristate, cetyl isooctanoate, neopentyl glycol dicaprate); silicone derivatives (eg, silicones such as methyl silicone and methyl phenyl silicone) Oil) and the like. Furthermore, oil-soluble vitamins, preservatives, whitening agents, and the like can be added.
上記界面活性剤としては、親油性非イオン界面活性剤、親水性非イオン界面活性剤等を挙げることができる。上記親油性非イオン界面活性剤としては特に限定されず、例えば、ソルビタンモノオレエート、ソルビタンモノイソステアレート、ソルビタンモノラウレート、ソルビタンモノパルミテート、ソルビタンモノステアレート、ソルビタンセスキオレエート、ソルビタントリオレエート、ペンタ−2−エチルヘキシル酸ジグリセロールソルビタン、テトラ−2−エチルヘキシル酸ジグリセロールソルビタン等のソルビタン脂肪酸エステル類、モノ綿実油脂肪酸グリセリン、モノエルカ酸グリセリン、セスキオレイン酸グリセリン、モノステアリン酸グリセリン、α,α’−オレイン酸ピログルタミン酸グリセリン、モノステアリン酸グリセリンリンゴ酸等のグリセリンポリグリセリン脂肪酸類、モノステアリン酸プロピレングリコール等のプロピレングリコール脂肪酸エステル類、硬化ヒマシ油誘導体、グリセリンアルキルエーテル等を挙げることができる。 Examples of the surfactant include a lipophilic nonionic surfactant and a hydrophilic nonionic surfactant. The lipophilic nonionic surfactant is not particularly limited. For example, sorbitan monooleate, sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan sesquioleate, sorbitan trioleate. Sorbitan fatty acid esters such as diglycerol sorbitan penta-2-ethylhexylate, diglycerol sorbitan tetra-2-ethylhexylate, mono-cotton oil fatty acid glycerin, glyceryl monoerucate, glyceryl sesquioleate, glyceryl monostearate, α, α '-Glycerol polyglycerin fatty acids such as glyceryl oleate pyroglutamate, glyceryl monostearate malate, propylene glycol monostearate Glycol fatty acid esters, hardened castor oil derivatives, glycerin alkyl ethers and the like.
親水性非イオン界面活性剤としては特に限定されず、例えば、POEソルビタンモノオレエート、POEソルビタンモノステアレート、POEソルビタンテトラオレエート等のPOEソルビタン脂肪酸エステル類、POEソルビットモノラウレート、POEソルビットモノオレエート、POEソルビットペンタオレエート、POEソルビットモノステアレート等のPOEソルビット脂肪酸エステル類、POEグリセリンモノステアレート、POEグリセリンモノイソステアレート、POEグリセリントリイソステアレート等のPOEグリセリン脂肪酸エステル類、POEモノオレエート、POEジステアレート、POEモノジオレエート、システアリン酸エチレングリコール等のPOE脂肪酸エステル類、POEラウリルエーテル、POEオレイルエーテル、POEステアリルエーテル、POEベヘニルエーテル、POE2−オクチルドデシルエーテル、POEコレスタノールエーテル等のPOEアルキルエーテル類、POEオクチルフェニルエーテル、POEノニルフェニルエーテル、POEジノニルフェニルエーテル等のPOEアルキルフェニルエーテル類、ブルロニック等のプルアロニック型類、POE・POPセチルエーテル、POE・POP2−デシルテトラデシルエーテル、POE・POPモノブチルエーテル、POE・POP水添ラノリン、POE・POPグリセリンエーテル等のPOE・POPアルキルエーテル類、テトロニック等のテトラPOE・テトラPOPエチレンジアミン縮合物類、POEヒマシ油、POE硬化ヒマシ油、POE硬化ヒマシ油モノイソステアレート、POE硬化ヒマシ油トリイソステアレート、POE硬化ヒマシ油モノピログルタミン酸モノイソステアリン酸ジエステル、POE硬化ヒマシ油マレイン酸等のPOEヒマシ油硬化ヒマシ油誘導体、POEソルビットミツロウ等のPOEミツロウ・ラノリン誘導体、ヤシ油脂肪酸ジエタノールアミド、ラウリン酸モノエタノールアミド、脂肪酸イソプロパノールアミド等のアルカノールアミド、POEプロピレングリコール脂肪酸エステル、POEアルキルアミン、POE脂肪酸アミド、ショ糖脂肪酸エステル、POEノニルフェニルホルムアルデヒド縮合物、アルキルエトキシジメチルアミンオキシド、トリオレイルリン酸等を挙げることができる。 The hydrophilic nonionic surfactant is not particularly limited. For example, POE sorbitan fatty acid esters such as POE sorbitan monooleate, POE sorbitan monostearate, POE sorbitan tetraoleate, POE sorbite monolaurate, and POE sorbite mono POE sorbite fatty acid esters such as oleate, POE sorbite pentaoleate, POE sorbite monostearate, POE glycerin fatty acid esters such as POE glycerol monostearate, POE glycerol monoisostearate, POE glycerol triisostearate, POE POE fatty acid esters such as monooleate, POE distearate, POE monodiolate, ethylene glycol stearate, POE lauryl ether, POE POE alkyl ethers such as yl ether, POE stearyl ether, POE behenyl ether, POE 2 -octyldodecyl ether, POE cholestanol ether, POE alkyl phenyl ethers such as POE octyl phenyl ether, POE nonyl phenyl ether, POE dinonyl phenyl ether Pluronic type such as brulonic, POE / POP cetyl ether, POE / POP2-decyltetradecyl ether, POE / POP monobutyl ether, POE / POP hydrogenated lanolin, POE / POP alkyl ethers such as POE / POP glycerin ether, Tetronic PEO / TetraPOP ethylenediamine condensates, POE castor oil, POE hydrogenated castor oil, POE hydrogenated castor oil monoisos POE castor oil triisostearate, POE cured castor oil monopyroglutamic acid monoisostearic acid diester, POE castor oil cured castor oil derivatives such as POE cured castor oil maleic acid, POE beeswax and lanolin derivatives such as POE sorbite beeswax, Alkanolamides such as coconut oil fatty acid diethanolamide, lauric acid monoethanolamide, fatty acid isopropanolamide, POE propylene glycol fatty acid ester, POE alkylamine, POE fatty acid amide, sucrose fatty acid ester, POE nonylphenyl formaldehyde condensate, alkylethoxydimethylamine Examples thereof include oxide and trioleyl phosphate.
その他の界面活性剤としては、例えば、脂肪酸セッケン、高級アルキル硫酸エステル塩、POEラウリル硫酸トリエタノールアミン、アルキルエーテル硫酸エステル塩等のアニオン界面活性剤、アルキルトリメチルアンモニウム塩、アルキルピリジニウム塩、アルキル四級アンモニウム塩、アルキルジメチルベンジルアンモニウム塩、POEアルキルアミン、アルキルアミン塩、ポリアミン脂肪酸誘導体等のカチオン界面活性剤、及び、イミダゾリン系両性界面活性剤、ベタイン系界面活性剤等の両性界面活性剤を安定性及び皮膚刺激性に問題のない範囲で配合してもよい。 Examples of other surfactants include anionic surfactants such as fatty acid soaps, higher alkyl sulfates, POE lauryl sulfate triethanolamine, alkyl ether sulfates, alkyltrimethylammonium salts, alkylpyridinium salts, alkyl quaternary salts. Stabilizes cationic surfactants such as ammonium salts, alkyldimethylbenzylammonium salts, POE alkylamines, alkylamine salts, polyamine fatty acid derivatives, and amphoteric surfactants such as imidazoline-based amphoteric surfactants and betaine-based surfactants. And you may mix | blend in the range which does not have a problem in skin irritation.
上記保湿剤としては特に限定されず、例えば、キシリトール、ソルビトール、マルチトール、ムコイチン硫酸、カロニン酸、アテロコラーゲン、コレステリル−12−ヒドロキシステアレート、乳酸ナトリウム、胆汁酸塩、dl−ピロリドンカルボン酸塩、短鎖可溶性コラーゲン、ジグリセリン(EO)PO付加物、イサイヨバラ抽出物、セイヨウノコギリソウ抽出物、メリロート抽出物等を挙げることができる。 The humectant is not particularly limited, and for example, xylitol, sorbitol, maltitol, mucoitin sulfate, caronic acid, atelocollagen, cholesteryl-12-hydroxystearate, sodium lactate, bile salt, dl-pyrrolidone carboxylate, short Examples include chain-soluble collagen, diglycerin (EO) PO adduct, Isaiyobara extract, yarrow extract, and merirot extract.
上記高級アルコールとしては特に限定されず、例えば、ラウリルアルコール、セチルアルコール、ステアリルアルコール、ベヘニルアルコール、ミリスチルアルコール、オレイルアルコール、セトステアリルアルコール等の直鎖アルコール、モノステアリルグリセリンエーテル(バチルアルコール)、2−デシルテトラデシノール、ラノリンアルコール、コレステロール、フィトステロール、ヘキシルドデカノール、イソステアリルアルコール、オクチルドデカノール等の分枝鎖アルコール等を挙げることができる。 The higher alcohol is not particularly limited, and examples thereof include linear alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol, monostearyl glycerin ether (batyl alcohol), 2-decyl. Examples thereof include branched chain alcohols such as tetradecinol, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, octyldodecanol, and the like.
金属イオン封鎖剤としては特に限定されず、例えば、1−ヒドロキシエタン−1,1− ジフォスホン酸、1−ヒドロキシエタン−1,1−ジフォスホン酸四ナトリウム塩、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸、リン酸、クエン酸、アスコルビン酸、コハク酸、エデト酸等を挙げることができる。 The sequestering agent is not particularly limited. For example, 1-hydroxyethane-1,1-diphosphonic acid, 1-hydroxyethane-1,1-diphosphonic acid tetrasodium salt, sodium citrate, sodium polyphosphate, metaphosphoric acid Examples thereof include sodium, gluconic acid, phosphoric acid, citric acid, ascorbic acid, succinic acid, edetic acid and the like.
上記天然の水溶性高分子としては特に限定されず、例えば、アラアビアガム、トラガカントガム、ガラクタン、グアガム、キャロブガム、カラヤガム、カラギーナン、ペクチン、カンテン、クインスシード(マルメロ)、アルゲコロイド(カッソウエキス)、デンプン(コメ、トウモロコシ、バレイショ、コムギ)、グリチルリチン酸等の植物系高分子、キサンタンガム、デキストラン、サクシノグルカン、プルラン等の微生物系高分子、コラーゲン、カゼイン、アルブミン、ゼラチン等の動物系高分子を挙げることができる。 The natural water-soluble polymer is not particularly limited. For example, arabia gum, tragacanth gum, galactan, guar gum, carob gum, caraya gum, carrageenan, pectin, agar, quince seed (malmello), alge colloid (guckweed extract), starch (rice, rice, Corn, potato, wheat), plant polymers such as glycyrrhizic acid, microbial polymers such as xanthan gum, dextran, succinoglucan and pullulan, and animal polymers such as collagen, casein, albumin and gelatin. .
半合成の水溶性高分子としては特に限定されず、例えば、カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系高分子、メチルセルロース、ニトロセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、セルロース硫酸ナトリウム、ヒドロキシプロピルセルロース、カルボキシメチルセルロースナトリウム(CMC)、結晶セルロース、セルロース末等のセルロース系高分子、アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系高分子等を挙げることができる。 The semi-synthetic water-soluble polymer is not particularly limited. For example, starch-based polymers such as carboxymethyl starch and methylhydroxypropyl starch, methylcellulose, nitrocellulose, ethylcellulose, methylhydroxypropylcellulose, hydroxyethylcellulose, sodium cellulose sulfate, Examples thereof include cellulose polymers such as hydroxypropylcellulose, sodium carboxymethylcellulose (CMC), crystalline cellulose, and cellulose powder, and alginic acid polymers such as sodium alginate and propylene glycol alginate.
合成の水溶性高分子としては特に限定されず、例えば、ポリビニルアルコール、ポリビニルメチルエーテル、ポリビニルピロリドン等のビニル系高分子、ポリエチレングリコール20,000、40,000、60,000等のポリオキシエチレン系高分子、ポリオキシエチレンポリオキシプロピレン共重合体共重合系高分子、ポリアクリル酸ナトリウム、ポリエチルアクリレート、ポリアクリルアミド等のアクリル系高分子、ポリエチレンイミン、カチオンポリマー、カルボキシビニルポリマー、アルキル変性カルボキシビニルポリマー等を挙げることができる。 The synthetic water-soluble polymer is not particularly limited, and examples thereof include vinyl polymers such as polyvinyl alcohol, polyvinyl methyl ether, and polyvinyl pyrrolidone, and polyoxyethylene polymers such as polyethylene glycol 20,000, 40,000, and 60,000. Polymer, polyoxyethylene polyoxypropylene copolymer copolymer polymer, acrylic polymer such as sodium polyacrylate, polyethyl acrylate, polyacrylamide, polyethyleneimine, cationic polymer, carboxyvinyl polymer, alkyl modified carboxyvinyl A polymer etc. can be mentioned.
無機の水溶性高分子としては特に限定されず、例えば、ベントナイト、ケイ酸AlMg(ビーガム)、ラポナイト、ヘクトライト、無水ケイ酸等を挙げることができる。 The inorganic water-soluble polymer is not particularly limited, and examples thereof include bentonite, silicate AlMg (beegum), laponite, hectorite, and silicic anhydride.
紫外線遮蔽剤としては特に限定されず、例えば、パラアミノ安息香酸(以下PABAと略す)、PABAモノグリセリンエステル、N,N−ジプロポキシPABAエチルエステル、N,N−ジエトキシPABAエチルエステル、N,N−ジメチルPABAエチルエステル、N,N−ジメチルPABAブチルエステル等の安息香酸系紫外線遮蔽剤;ホモメンチル−N−アセチルアントラニレート等のアントラニル酸系紫外線遮蔽剤;アミルサリシレート、メンチルサリシレート、ホモメンチルサリシレート、オクチルサリシレート、フェニルサリシレート、ベンジルサリシレート、p−イソプロパノールフェニルサリシレート等のサリチル酸系紫外線遮蔽剤;オクチルシンナメート、エチル−4−イソプロピルシンナメート、メチル−2,5−ジイソプロピルシンナメート、エチル−2,4−ジイソプロピルシンナメート、メチル−2,4−ジイソプロピルシンナメート、プロピル−p−メトキシシンナメート、イソプロピル−p−メトキシシンナメート、イソアミル−p−メトキシシンナメート、2−エトキシエチル−p−メトキシシンナメート、シクロヘキシル−p−メトキシシンナメート、エチル−α−シアノ−β−フェニルシンナメート、2−エチルヘキシル−α−シアノ−β−フェニルシンナメート、グリセリルモノ−2−エチルヘキサノイル−ジパラメトキシシンナメート等のケイ皮酸系紫外線遮蔽剤;2,4−ジヒドロキシベンゾフェノン、2,2’−ジヒドロキシ−4−メトキシベンゾフェノン、2,2’−ジヒドロキシ−4,4’−ジメトキシベンゾフェノン、2,2’,4,4’−テトラヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシ−4’−メチルベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸塩、4−フェニルベンゾフェノン、2−エチルヘキシル−4’−フェニル−ベンゾフェノン−2−カルボキシレート、2−ヒドロキシ−4−n−オクトキシベンゾフェノン、4−ヒドロキシ−3− カルボキシベンゾフェノン等のベンゾフェノン系紫外線遮蔽剤;3−(4’−メチルベンジリデン)−d,l−カンファー、3−ベンジリデン−d,l−カンファー、ウロカニン酸、ウロカニン酸エチルエステル、2−フェニル−5−メチルベンゾキサゾール、2,2’−ヒドロキシ−5−メチルフェニルベンゾトリアゾール、2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、2−(2’−ヒドロキシ−5’−メチルフェニルベンゾトリアゾール、ジベンザラジン、ジアニソイルメタン、4−メトキシ−4’−t−ブチルジベンゾイルメタン、5−(3,3−ジメチル−2−ノルボルニリデン)−3−ペンタン−2−オン等を挙げることができる。 The ultraviolet screening agent is not particularly limited. For example, paraaminobenzoic acid (hereinafter abbreviated as PABA), PABA monoglycerin ester, N, N-dipropoxy PABA ethyl ester, N, N-diethoxy PABA ethyl ester, N, N-dimethyl Benzoic acid UV screening agents such as PABA ethyl ester and N, N-dimethyl PABA butyl ester; Anthranilic acid UV screening agents such as homomenthyl-N-acetylanthranylate; Amyl salicylate, menthyl salicylate, homomenthyl salicylate, octyl salicylate , Salicylic acid UV screening agents such as phenyl salicylate, benzyl salicylate, p-isopropanol phenyl salicylate; octylcinnamate, ethyl-4-isopropylcinnamate, methyl-2,5- Isopropyl cinnamate, ethyl-2,4-diisopropyl cinnamate, methyl-2,4-diisopropyl cinnamate, propyl-p-methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p-methoxycinnamate, 2- Ethoxyethyl-p-methoxycinnamate, cyclohexyl-p-methoxycinnamate, ethyl-α-cyano-β-phenylcinnamate, 2-ethylhexyl-α-cyano-β-phenylcinnamate, glyceryl mono-2-ethylhexa Cinnamic acid-based ultraviolet screening agents such as noyl-diparamethoxycinnamate; 2,4-dihydroxybenzophenone, 2,2′-dihydroxy-4-methoxybenzophenone, 2,2′-dihydroxy-4,4′-dimethoxybenzophenone , 2, 2 ', 4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonate, 4 -Benzophenone-based UV shielding agents such as phenylbenzophenone, 2-ethylhexyl-4'-phenyl-benzophenone-2-carboxylate, 2-hydroxy-4-n-octoxybenzophenone, 4-hydroxy-3-carboxybenzophenone; (4′-methylbenzylidene) -d, l-camphor, 3-benzylidene-d, l-camphor, urocanic acid, urocanic acid ethyl ester, 2-phenyl-5-methylbenzoxazole, 2,2′-hydroxy- 5-methylphenylbenzoto Azole, 2- (2′-hydroxy-5′-t-octylphenyl) benzotriazole, 2- (2′-hydroxy-5′-methylphenylbenzotriazole), dibenzalazine, dianisoylmethane, 4-methoxy-4′- Examples thereof include t-butyldibenzoylmethane and 5- (3,3-dimethyl-2-norbornylidene) -3-pentan-2-one.
その他薬剤成分としては特に限定されず、例えば、ビタミンA油、レチノール、パルミチン酸レチノール、イノシット、塩酸ピリドキシン、ニコチン酸ベンジル、ニコチン酸アミド、ニコチン酸DL−α−トコフェロール、アルコルビン酸リン酸マグネシウム、2−O−α−D−グルコピラノシル−L−アスコルビン酸、ビタミンD2(エルゴカシフェロール)、dl−α−トコフェロール、酢酸dl−α−トコフェロール、パントテン酸、ビオチン等のビタミン類;エストラジオール、エチニルエストラジオール等のホルモン;アルギニン、アスパラギン酸、シスチン、システイン、メチオニン、セリン、ロイシン、トリプトファン等のアミノ酸;アラントイン、アズレン等の抗炎症剤、アルブチン等の美白剤、;タンニン酸等の収斂剤;L−メントール、カンフル等の清涼剤やイオウ、塩化リゾチーム、塩化ピリドキシン等を挙げることができる。 Other drug components are not particularly limited and include, for example, vitamin A oil, retinol, retinol palmitate, inosit, pyridoxine hydrochloride, benzyl nicotinate, nicotinamide, nicotinic acid DL-α-tocopherol, magnesium ascorbate phosphate, 2 Vitamins such as -O-α-D-glucopyranosyl-L-ascorbic acid, vitamin D2 (ergocaciferol), dl-α-tocopherol, dl-α-tocopherol acetate, pantothenic acid, biotin; estradiol, ethinylestradiol, etc. Hormones; amino acids such as arginine, aspartic acid, cystine, cysteine, methionine, serine, leucine and tryptophan; anti-inflammatory agents such as allantoin and azulene; whitening agents such as arbutin; astringents such as tannic acid; L Menthol, cooling agents and sulfur camphor such as, lysozyme chloride, can be mentioned pyridoxine chloride, and the like.
各種の抽出液としては特に限定されず、例えば、ドクダミエキス、オウバクエキス、メリロートエキス、オドリコソウエキス、カンゾウエキス、シャクヤクエキス、サボンソウエキス、ヘチマエキス、キナエキス、ユキノシタエキス、クララエキス、コウホネエキス、ウイキョウエキス、サクラソウエキス、バラエキス、ジオウエキス、レモンエキス、シコンエキス、アロエエキス、ショウブ根エキス、ユーカリエキス、スギナエキス、セージエキス、タイムエキス、茶エキス、海藻エキス、キューカンバーエキス、チョウジエキス、キイチゴエキス、メリッサエキス、ニンジンエキス、マロニエエキス、モモエキス、桃葉エキス、クワエキス、ヤグルマギクエキス、ハマメリスエキス、プラセンタエキス、胸腺抽出物、シルク抽出液、甘草エキス等を挙げることができる。 There are no particular limitations on the various extracts, for example, Dokudami extract, Oat extract, Merirot extract, Odorikosou extract, Licorice extract, Peonies extract, Soap extract, Loofah extract, Kina extract, Yukinoshita extract, Clara extract, Kouhone extract, Fennel Extract, Primrose Extract, Rose Extract, Giant Extract, Lemon Extract, Shikon Extract, Aloe Extract, Shobu Root Extract, Eucalyptus Extract, Horsetail Extract, Sage Extract, Thyme Extract, Tea Extract, Seaweed Extract, Cucumber Extract, Clove Extract, Raspberry Extract, Melissa Extract , Carrot extract, marronnier extract, peach extract, peach leaf extract, mulberry extract, cornflower extract, hamamelis extract, placenta extract, thymus extract, silk extract, licorice Mention may be made of the kiss and the like.
本発明を実施例に基づいてさらに詳細に説明するが、本発明はこれらの実施例のみに限定されるものではない。なお、実施例、比較例において特に断りのない限り、「%」は重量%を意味する。 EXAMPLES Although this invention is demonstrated further in detail based on an Example, this invention is not limited only to these Examples. In Examples and Comparative Examples, “%” means% by weight unless otherwise specified.
実施例1(酸化チタン水系分散体の製造)
1,3−ブチレングリコール13.0gにKF−6013(PEG−9ジメチコン:信越化学工業株式会社製;HLB 10.0)12.0gとシリコーンで表面処理されているシリカ表面処理微粒子酸化チタン(堺化学工業株式会社製STR−100W−LPT:粒子径短軸20nm、長軸100nmの紡錘状粒子)50.0gを混合した後、精製水25.0gを加え、撹拌した。さらに、ヒアルロン酸ナトリウム水溶液(株式会社資生堂製、バイオヒアルロン酸ナトリウム 1%水溶液(PE)N)200gを加え、攪拌し、酸化チタン100重量部に対して、ヒアルロン酸ナトリウムを4重量部含有する、酸化チタン水系分散体を作製した。
Example 1 (Production of titanium oxide aqueous dispersion)
13.0 g of 1,3-butylene glycol and 12.0 g of KF-6013 (PEG-9 dimethicone: manufactured by Shin-Etsu Chemical Co., Ltd .; HLB 10.0) and silica surface-treated fine particle titanium oxide (堺) STR-100W-LPT manufactured by Kagaku Kogyo Co., Ltd .: 50.0 g of spindle-shaped particles having a minor axis of 20 nm and a major axis of 100 nm were mixed, and then 25.0 g of purified water was added and stirred. Furthermore, 200 g of sodium hyaluronate aqueous solution (manufactured by Shiseido Co., Ltd., sodium biohyaluronate 1% aqueous solution (PE) N) is added, stirred, and contains 4 parts by weight of sodium hyaluronate with respect to 100 parts by weight of titanium oxide. A titanium oxide aqueous dispersion was prepared.
実施例2(酸化亜鉛水系分散体の製造)
1,3−ブチレングリコール10.0gにKF−6013(PEG−9ジメチコン:信越化学工業株式会社製)5.0gとシリコーンで表面処理されているシリカ表面処理微粒子酸化亜鉛(堺化学工業社製FINEX−33W−LP2:平均粒子径35nm)60.0gを混合した後、水25.0gを加え、撹拌した。さらにヒアルロン酸ナトリウム水溶液(株式会社資生堂製、バイオヒアルロン酸ナトリウム 1%水溶液(PE)N)200gを加え、撹拌し、酸化亜鉛100重量部に対し、ヒアルロン酸ナトリウム3.34重量部含有する酸化亜鉛水系分散体を作製した。
Example 2 (Production of aqueous zinc oxide dispersion)
Silica surface-treated fine particle zinc oxide (FINEX manufactured by Sakai Chemical Industry Co., Ltd.) surface-treated with 5.0 g of KF-6013 (PEG-9 dimethicone: manufactured by Shin-Etsu Chemical Co., Ltd.) and 10.0 g of 1,3-butylene glycol -33W-LP2: average particle diameter 35 nm) After mixing 60.0 g, 25.0 g of water was added and stirred. Furthermore, 200 g of sodium hyaluronate aqueous solution (manufactured by Shiseido Co., Ltd., biohyaluronic acid sodium 1% aqueous solution (PE) N) was added, stirred, and zinc oxide containing 3.34 parts by weight of sodium hyaluronate with respect to 100 parts by weight of zinc oxide. An aqueous dispersion was prepared.
実施例3(酸化チタン、酸化亜鉛の混合水系分散体の製造)
1,3−ブチレングリコール53.0gにKF−6013(PEG−9ジメチコン:信越化学工業株式会社製)32.0gとシリコーンで表面処理されているシリカ表面処理微粒子酸化亜鉛(堺化学工業社製FINEX−33W−LP2:平均粒子径35nm)240g、シリコーンで表面処理されているシリカ表面処理微粒子酸化チタン(堺化学工業株式会社製STR−100W−LPT:粒子径短軸20nm、長軸100nmの紡錘状粒子)50.0gを混合した後、水125.0gを加え、撹拌した。さらに、ヒアルロン酸ナトリウム水溶液(株式会社資生堂製、バイオヒアルロン酸ナトリウム1%水溶液(PE)N)100gを加え、撹拌し、酸化チタンおよび酸化亜鉛の合計100重量部に対して、ヒアルロン酸ナトリウム0.35重量部含有する酸化チタンと酸化亜鉛を含む水系分散体を作製した。
Example 3 (Production of a mixed aqueous dispersion of titanium oxide and zinc oxide)
13.0-butylene glycol 53.0 g, KF-6013 (PEG-9 dimethicone: manufactured by Shin-Etsu Chemical Co., Ltd.) 32.0 g of silica surface-treated fine zinc oxide (FINEX manufactured by Sakai Chemical Industry Co., Ltd.) -33W-LP2: 240 g of silica, surface-treated fine particle titanium oxide surface-treated with silicone (STR-100W-LPT, manufactured by Sakai Chemical Industry Co., Ltd .: spindle shape with a particle diameter of 20 nm short axis and 100 nm long axis) Particles) After mixing 50.0 g, 125.0 g of water was added and stirred. Furthermore, 100 g of sodium hyaluronate aqueous solution (manufactured by Shiseido Co., Ltd., 1% sodium biohyaluronate aqueous solution (PE) N) was added and stirred, and 0.1% of sodium hyaluronate was added to 100 parts by weight of titanium oxide and zinc oxide. An aqueous dispersion containing 35 parts by weight of titanium oxide and zinc oxide was prepared.
実施例4(酸化亜鉛水系分散体の製造)
1,3−ブチレングリコール10.0gにKF−6013(PEG−9ジメチコン:信越化学工業株式会社製)5.0gとシリコーンで表面処理されているシリカ表面処理微粒子酸化亜鉛(堺化学工業社製FINEX−33W−LP2:平均粒子径35nm)60.0gを混合した後、水25.0gを加え、撹拌した。さらにヒアルロン酸ナトリウム水溶液(株式会社資生堂製、バイオヒアルロン酸ナトリウム 1%水溶液(PE)N)33.0gを加え、撹拌、酸化亜鉛100重量部に対して、ヒアルロン酸ナトリウム0.55重量部含有する酸化亜鉛水系分散体を作製した。
Example 4 (Production of aqueous zinc oxide dispersion)
Silica surface-treated fine particle zinc oxide (FINEX manufactured by Sakai Chemical Industry Co., Ltd.) surface-treated with 5.0 g of KF-6013 (PEG-9 dimethicone: manufactured by Shin-Etsu Chemical Co., Ltd.) and 10.0 g of 1,3-butylene glycol -33W-LP2: average particle diameter 35 nm) After mixing 60.0 g, 25.0 g of water was added and stirred. Further, 33.0 g of sodium hyaluronate aqueous solution (manufactured by Shiseido Co., Ltd., biohyaluronic acid sodium 1% aqueous solution (PE) N) was added, and the mixture contained 0.55 parts by weight of sodium hyaluronate with respect to 100 parts by weight of zinc oxide. A zinc oxide aqueous dispersion was prepared.
実施例5(酸化チタン、酸化亜鉛の混合水系分散体の製造)
1,3−ブチレングリコール23.0gにKF−6013(PEG−9ジメチコン:信越化学工業株式会社製)17.0gとシリコーンで表面処理されているシリカ表面処理微粒子酸化亜鉛(堺化学工業社製FINEX−33W−LP2:平均粒子径35nm)60.0g、シリコーンで表面処理されているシリカ表面処理微粒子酸化チタン(堺化学工業株式会社製STR−100W−LPT:粒子径短軸20nm、長軸100nmの紡錘状粒子)50.0gを混合した後、水50.0gを加え、撹拌した。さらに、ヒアルロン酸ナトリウム水溶液(株式会社資生堂製、バイオヒアルロン酸ナトリウム 1%水溶液(PE)N)50.0gを加え、撹拌し、酸化チタンおよび酸化亜鉛の合計100重量部に対して、ヒアルロン酸ナトリウム0.46重量部含有する酸化チタンと酸化亜鉛を含む水系分散体を作製した。
Example 5 (Production of mixed aqueous dispersion of titanium oxide and zinc oxide)
13.0 g of KF-6013 (PEG-9 dimethicone: manufactured by Shin-Etsu Chemical Co., Ltd.) and 23.0 g of 1,3-butylene glycol and silica surface-treated fine particle zinc oxide (FINEX manufactured by Sakai Chemical Industry Co., Ltd.) -33W-LP2: average particle diameter 35 nm) 60.0 g, silica surface-treated fine particle titanium oxide surface-treated with silicone (manufactured by Sakai Chemical Industry Co., Ltd. STR-100W-LPT: particle diameter minor axis 20 nm, major axis 100 nm After mixing 50.0 g of spindle-shaped particles), 50.0 g of water was added and stirred. Further, 50.0 g of a sodium hyaluronate aqueous solution (manufactured by Shiseido Co., Ltd., 1% aqueous sodium biohyaluronate (PE) N) was added, stirred, and sodium hyaluronate with respect to 100 parts by weight of titanium oxide and zinc oxide in total. An aqueous dispersion containing 0.46 parts by weight of titanium oxide and zinc oxide was produced.
実施例6(酸化チタン、酸化亜鉛の混合水系分散体の製造)
1,3−ブチレングリコール43.0gにKF−6013(PEG−9ジメチコン:信越化学工業株式会社製)27.0gとシリコーンで表面処理されているシリカ表面処理微粒子酸化亜鉛(堺化学工業社製FINEX−33W−LP2:平均粒子径35nm)180.0g、シリコーンで表面処理されているシリカ表面処理微粒子酸化チタン(堺化学工業株式会社製STR−100W−LPT:粒子径短軸20nm、長軸100nmの紡錘状粒子)50.0gを混合した後、水100.0gを加え、撹拌した。さらに、ヒアルロン酸ナトリウム水溶液(株式会社マツモト交商製、マツヒアロ HA−LQ 1%水溶液)100gを加え、撹拌し、酸化チタンおよび酸化亜鉛の合計100重量部に対して、ヒアルロン酸ナトリウム0.44重量部含有する酸化チタンと酸化亜鉛を含む水系分散体を作製した。
Example 6 (Production of mixed aqueous dispersion of titanium oxide and zinc oxide)
23.0 g of KF-6013 (PEG-9 dimethicone: manufactured by Shin-Etsu Chemical Co., Ltd.) and 43.0 g of 1,3-butylene glycol and silica surface-treated fine particle zinc oxide (FINEX manufactured by Sakai Chemical Industry Co., Ltd.) -33W-LP2: average particle diameter 35 nm) 180.0 g, silica surface-treated fine particle titanium oxide surface-treated with silicone (manufactured by Sakai Chemical Industry Co., Ltd. STR-100W-LPT: particle diameter minor axis 20 nm, major axis 100 nm After mixing 50.0 g of spindle-shaped particles, 100.0 g of water was added and stirred. Furthermore, 100 g of sodium hyaluronate aqueous solution (manufactured by Matsumoto Co., Ltd., Matsuhiaro HA-LQ 1% aqueous solution) was added and stirred, and sodium hyaluronate was 0.44 weight with respect to 100 parts by weight of titanium oxide and zinc oxide in total. An aqueous dispersion containing titanium oxide and zinc oxide contained in part was prepared.
比較例1、2
実施例1の酸化チタンの水系分散体の作製工程において、ヒアルロン酸ナトリウム水溶液の代わりに、それぞれキサンタンガム水溶液(DSP五協フード&ケミカル株式会社製 ケルデントを精製水で2%水溶液にしたもの)200gまたは、シロキクラゲ多糖体水溶液(日本精化株式会社製、Trimoist−SLを精製水で1%水溶液にしたもの)200gを添加して酸化チタン水系分散体を作製した。
Comparative Examples 1 and 2
In the production process of the titanium oxide aqueous dispersion of Example 1, in place of the sodium hyaluronate aqueous solution, xanthan gum aqueous solution (DSP Gokyo Food & Chemical Co., Ltd. Keldent made into 2% aqueous solution with purified water) 200 g or 200 g of a white jellyfish polysaccharide aqueous solution (Nippon Seika Co., Ltd., Trimoist-SL made into 1% aqueous solution with purified water) was added to prepare a titanium oxide aqueous dispersion.
比較例3(ヒアルロン酸添加なし酸化チタン水系分散体)
1,3−ブチレングリコール13.0gにKF−6013(PEG−9ジメチコン:信越化学工業株式会社製;HLB 10.0)12.0gとシリコーンで表面処理されているシリカ表面処理微粒子酸化チタン(堺化学工業株式会社製STR−100W−LPT:粒子径短軸20nm、長軸100nmの紡錘状粒子)50.0gを混合した後、精製水25.0gを加え、攪拌、酸化チタン水系分散体を作製した。
Comparative Example 3 (Titanium oxide aqueous dispersion without addition of hyaluronic acid)
13.0 g of 1,3-butylene glycol and 12.0 g of KF-6013 (PEG-9 dimethicone: manufactured by Shin-Etsu Chemical Co., Ltd .; HLB 10.0) and silica surface-treated fine particle titanium oxide (堺) STR-100W-LPT manufactured by Chemical Industry Co., Ltd .: Spindle-shaped particles with a minor axis of 20 nm and a major axis of 100 nm were mixed, and then 25.0 g of purified water was added, followed by stirring to prepare a titanium oxide aqueous dispersion. did.
比較例4(ヒアルロン酸なし酸化亜鉛分散体)
1,3−ブチレングリコール10.0gにKF−6013(PEG−9ジメチコン:信越化学工業株式会社製)5.0gとシリコーンで表面処理されているシリカ表面処理微粒子酸化亜鉛(堺化学工業社製FINEX−33W−LP2:平均粒子径35nm)60.0gを混合した後、水25.0gを加え、攪拌、酸化亜鉛水系分散体を作製した。
Comparative Example 4 (Zinc oxide dispersion without hyaluronic acid)
Silica surface-treated fine particle zinc oxide (FINEX manufactured by Sakai Chemical Industry Co., Ltd.) surface-treated with 5.0 g of KF-6013 (PEG-9 dimethicone: manufactured by Shin-Etsu Chemical Co., Ltd.) and 10.0 g of 1,3-butylene glycol -33W-LP2: average particle diameter 35 nm) After mixing 60.0 g, 25.0 g of water was added and stirred to prepare a zinc oxide aqueous dispersion.
比較例5(ヒアルロン酸を同時添加に変更した分散体)
1,3−ブチレングリコール13.0gにKF−6013(PEG−9ジメチコン:信越化学工業株式会社製;HLB 10.0)12.0g、シリコーンで表面処理されているシリカ表面処理微粒子酸化チタン(堺化学工業株式会社製STR−100W−LPT:粒子径短軸20nm、長軸100nmの紡錘状粒子)50.0g、精製水25.0g、ヒアルロン酸ナトリウム水溶液(株式会社資生堂製、バイオヒアルロン酸ナトリウム 1%水溶液(PE)N)200gを同時に加えて、撹拌したが、粉体がなじまず、ダマが多く見られる状態になり、分散体が作製できなかった。
Comparative Example 5 (dispersion in which hyaluronic acid was changed to simultaneous addition)
13.0 g of 1,3-butylene glycol, 12.0 g of KF-6013 (PEG-9 dimethicone: manufactured by Shin-Etsu Chemical Co., Ltd .; HLB 10.0), silica surface-treated fine particle titanium oxide (堺) STR-100W-LPT manufactured by Chemical Industry Co., Ltd .: 50.0 g of spindle-shaped particles having a minor axis of 20 nm and a major axis of 100 nm, 25.0 g of purified water, sodium hyaluronate aqueous solution (manufactured by Shiseido Co., Ltd., sodium biohyaluronate % Aqueous solution (PE) N) 200 g was added and stirred at the same time, but the powder did not conform and a lot of lumps were seen, and a dispersion could not be produced.
比較例6(ヒアルロン酸なし酸化チタン、酸化亜鉛の混合水系分散体)
1,3−ブチレングリコール23.0gにKF−6013(PEG−9ジメチコン:信越化学工業株式会社製)17.0gとシリコーンで表面処理されているシリカ表面処理微粒子酸化亜鉛(堺化学工業社製FINEX−33W−LP2:平均粒子径35nm)60.0g、シリコーンで表面処理されているシリカ表面処理微粒子酸化チタン(堺化学工業株式会社製STR−100W−LPT:粒子径短軸20nm、長軸100nmの紡錘状粒子)50.0gを混合した後、水50.0gを加え、撹拌し、酸化チタンと酸化亜鉛を含む水系分散体を作製した。
Comparative Example 6 (mixed aqueous dispersion of titanium oxide and zinc oxide without hyaluronic acid)
13.0 g of KF-6013 (PEG-9 dimethicone: manufactured by Shin-Etsu Chemical Co., Ltd.) and 23.0 g of 1,3-butylene glycol and silica surface-treated fine particle zinc oxide (FINEX manufactured by Sakai Chemical Industry Co., Ltd.) -33W-LP2: average particle diameter 35 nm) 60.0 g, silica surface-treated fine particle titanium oxide surface-treated with silicone (manufactured by Sakai Chemical Industry Co., Ltd. STR-100W-LPT: particle diameter minor axis 20 nm, major axis 100 nm After mixing 50.0 g of spindle-shaped particles), 50.0 g of water was added and stirred to prepare an aqueous dispersion containing titanium oxide and zinc oxide.
(カルボキシビニルポリマーとの併用試験)
カルボキシビニルポリマー(Carbopol 980:Lubrizol社製)2gを精製水98gに投入し、少量の10%水酸化ナトリウム水溶液を添加してpH7に調整し、カルボキシビニルポリマー粘稠液を作製した。得られたカルボキシビニルポリマー粘稠液6.4gと、実施例1〜6および比較例1、2の水系分散体15.0g、水8.6gを混合し、調製した組成物の外観を目視で確認し、次のように評価した。また、比較例3、4の水系分散体5.0gと、上記で得られたカルボキシビニルポリマー粘稠液6.4g、水18.6gを混合し、同様に評価した。(試験No.1〜10)
○…凝集がなく、組成物の表面も凸凹がなく滑らかである。
△…凝集は確認されないものの、組成物の表面が不均一で凸凹の部分がある。
×…組成物の一部に凝集が見られ、その表面も滑らかでなくツヤもなく、ボコボコしている。
(Combination test with carboxyvinyl polymer)
2 g of carboxyvinyl polymer (Carbopol 980: manufactured by Lubrizol) was added to 98 g of purified water, and a small amount of 10% aqueous sodium hydroxide solution was added to adjust the pH to 7 to prepare a carboxyvinyl polymer viscous liquid. 6.4 g of the obtained carboxyvinyl polymer viscous liquid was mixed with 15.0 g of the aqueous dispersions of Examples 1 to 6 and Comparative Examples 1 and 2 and 8.6 g of water, and the appearance of the prepared composition was visually observed. It confirmed and evaluated as follows. Moreover, 5.0 g of the aqueous dispersions of Comparative Examples 3 and 4, 6.4 g of the carboxyvinyl polymer viscous liquid obtained above and 18.6 g of water were mixed and evaluated in the same manner. (Test Nos. 1 to 10)
○: There is no aggregation and the surface of the composition is smooth without any irregularities.
Δ: Although aggregation is not confirmed, the surface of the composition is uneven and has uneven portions.
X: Agglomeration was observed in a part of the composition, the surface was not smooth and glossy, and it was bumpy.
上記の通り、本発明の水系分散体を用いると、カルボキシビニルポリマーとの併用を行っても組成物の凝集が起こらず、安定性に優れた組成物を得ることができる。したがって、カルボキシビニルポリマーにより増粘した化粧料にも、好適に適用することができる。 As described above, when the aqueous dispersion of the present invention is used, the composition does not aggregate even when used in combination with a carboxyvinyl polymer, and a composition having excellent stability can be obtained. Therefore, it can be suitably applied to cosmetics thickened by carboxyvinyl polymer.
((アクリロイルジメチルタウリンアンモニウム/ビニルピロリドン)コポリマーとの併用による長期安定性試験)
(アクリロイルジメチルタウリンアンモニウム/ビニルピロリドン)コポリマー(クラリアント製、「Aristoflex AVC」)の2%水溶液30gを、精製水44.7gに投入し、混合した。さらに、実施例5で得られた分散体25g、フェノキシエタノール(クラリアント製 Phenoxetol)0.3gを加えて混合し、得られた組成物を室温および50℃で1ヶ月間静置し、組成物の外観を目視で観察した。(試験No.11)
また、(アクリロイルジメチルタウリンアンモニウム/ビニルピロリドン)コポリマー(クラリアント製、「Aristoflex AVC」)の2%水溶液30gを、精製水49.7gに投入し、混合した。さらに、比較例6で得られた分散体20g、フェノキシエタノール(クラリアント製 Phenoxetol)0.3gを加えて混合し、得られた組成物を同様に観察した。(試験No.12)
(Long-term stability test in combination with (acryloyldimethyltauronium ammonium / vinylpyrrolidone) copolymer)
30 g of a 2% aqueous solution of (acryloyldimethyltaurine ammonium / vinylpyrrolidone) copolymer (manufactured by Clariant, “Aristoflex AVC”) was added to 44.7 g of purified water and mixed. Furthermore, 25 g of the dispersion obtained in Example 5 and 0.3 g of phenoxyethanol (Phenoxetol manufactured by Clariant) were added and mixed, and the resulting composition was allowed to stand at room temperature and 50 ° C. for 1 month, and the appearance of the composition Was visually observed. (Test No. 11)
Further, 30 g of a 2% aqueous solution of (acryloyldimethyltaurate ammonium / vinylpyrrolidone) copolymer (manufactured by Clariant, “Aristoflex AVC”) was added to 49.7 g of purified water and mixed. Furthermore, 20 g of the dispersion obtained in Comparative Example 6 and 0.3 g of phenoxyethanol (Phenoxetol manufactured by Clariant) were added and mixed, and the resulting composition was similarly observed. (Test No. 12)
△…凝集は確認されないものの、組成物の表面が不均一で凸凹の部分がある。
×…組成物の一部に凝集が見られ、その表面も滑らかでなくツヤもなく、ボコボコしている。
Δ: Although aggregation is not confirmed, the surface of the composition is uneven and has uneven portions.
X: Agglomeration was observed in a part of the composition, the surface was not smooth and glossy, and it was bumpy.
上記の通り、本発明の水系分散体を用いると、アニオン系増粘剤の1種である(アクリロイルジメチルタウリンアンモニウム/ビニルピロリドン)コポリマーとの併用を行っても組成物の凝集が起こらず、安定性に優れた組成物を得ることができる。したがって、上記増粘剤により増粘した化粧料にも、好適に適用することができる。 As described above, when the aqueous dispersion of the present invention is used, the composition is not agglomerated even when used in combination with (acryloyldimethyltaurine ammonium / vinylpyrrolidone) copolymer, which is one of anionic thickeners, and stable. A composition having excellent properties can be obtained. Therefore, it can be suitably applied to cosmetics thickened by the thickener.
(処方例1)
下記表4に示した処方に基づき、水中油型乳化化粧料を作成した。
(Prescription Example 1)
Based on the formulation shown in Table 4 below, an oil-in-water emulsified cosmetic was prepared.
1)Innovacos社製、ステアリン酸ポリグリセリル−2、ステアリン酸グリセリル、ステアリルアルコール
2)AAK社製、シア脂エチルエステルズ
[製造手順]
(1)1、2、3を加熱溶解する(75±5℃)
(2)(1)に4、5、6、7、8を順次添加し均一混合する(80〜85℃)
(3)(2)に予め80〜85℃に加温した9を徐々に添加し、乳化する(D=3000rpm、3分、80〜85℃)
(4)(3)を40℃まで冷却する
(5)(4)に10を添加し均一混合する
(6)(5)に11を添加し、均一混合する
(7)(6)に12、13を順次添加し、均一混合する
1) manufactured by Innovacos, polyglyceryl stearate-2, glyceryl stearate, stearyl alcohol 2) manufactured by AAK, shea fat ethyl esters [production procedure]
(1) Heat, dissolve 1, 2, and 3 (75 ± 5 ° C)
(2) Add 4, 5, 6, 7, and 8 sequentially to (1) and mix uniformly (80 to 85 ° C.)
(3) Gradually add 9 preheated to 80-85 ° C to (2) and emulsify (D = 3000rpm, 3 minutes, 80-85 ° C)
(4) Cool (3) to 40 ° C. (5) Add 10 to (4) and mix uniformly
(6) Add 11 to (5) and mix uniformly (7) Add 12 and 13 to (6) sequentially and mix uniformly
(参考例)
上記処方例1における製造手順(6)において、11の実施例3の水系分散体の代わりに、比較例3の酸化チタン水系分散体5部と比較例4の酸化亜鉛水系分散体20部、ヒアルロン酸Na1%水溶液5部を事前に均一混合することなく、添加した。得られた水中油型乳化化粧料は、安定性が悪かった。
(Reference example)
In the production procedure (6) in the above Formulation Example 1, instead of the aqueous dispersion of Example 3, 11 parts of the titanium oxide aqueous dispersion of Comparative Example 3, 20 parts of the zinc oxide aqueous dispersion of Comparative Example 4, and hyaluron The acid Na 1% aqueous solution 5 parts was added without uniform mixing in advance. The oil-in-water emulsified cosmetic obtained was poor in stability.
(処方例2)
下記表5に示した処方に基づき、水中油型乳化化粧料を作成した。
(Prescription example 2)
Based on the formulation shown in Table 5 below, an oil-in-water emulsified cosmetic was prepared.
4)BASF製、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、メトキシケイヒ酸エチルヘキシル
5)東レ・ダウコーニング製、PEG/PPG−30/10ジメチコン、他
[製造手順]
(1)2、3を加熱溶解した後、1を添加し、均一に混合する。
(2)(1)に4を添加し、乳化する。(D=3000rpm、3分)
(3)5〜11を均一混合する。
(4)(2)に(3)を添加し、乳化する。(D=3000rpm、3分)
(5)(4)に12を添加し、均一混合する。
(6)(5)に13を添加し、均一混合する。
(7)(6)に14を添加し、均一混合する。
[Manufacturing procedure]
(1) After 2 and 3 are dissolved by heating, 1 is added and mixed uniformly.
(2) Add 4 to (1) and emulsify. (D = 3000rpm, 3 minutes)
(3) Uniformly mix 5-11.
(4) Add (3) to (2) and emulsify. (D = 3000rpm, 3 minutes)
(5) Add 12 to (4) and mix uniformly.
(6) Add 13 to (5) and mix uniformly.
(7) Add 14 to (6) and mix uniformly.
(処方例3)
下記表6に示した処方に基づき、水中油型リキッドファンデーションを作成した。
(Prescription Example 3)
Based on the formulation shown in Table 6 below, an oil-in-water liquid foundation was prepared.
[製造手順]
(1)1〜7を70℃に加熱して溶解し、均一混合する。
(2)8〜11を70℃に加熱して溶解し、均一混合する。
(3)(1)に(2)を添加し、乳化する。(D=1000rpm、70℃、2分間)
(4)(3)を35℃まで冷却する。
(5)12〜18をローラー処理し、(4)に添加し、均一に混合する。
(6)19を(5)に添加し、均一に混合する。
[Manufacturing procedure]
(1) Heat 1 to 7 at 70 ° C. to dissolve and mix uniformly.
(2) Heat 8 to 11 at 70 ° C. to dissolve and uniformly mix.
(3) Add (2) to (1) and emulsify. (D = 1000 rpm, 70 ° C., 2 minutes)
(4) Cool (3) to 35 ° C.
(5) Roll 12-18 and add to (4) and mix uniformly.
(6) Add 19 to (5) and mix uniformly.
本発明の水系分散体は、日焼け止め化粧料、メイクアップ化粧料、その他の各種化粧料として利用することができる。 The aqueous dispersion of the present invention can be used as sunscreen cosmetics, makeup cosmetics, and other various cosmetics.
Claims (7)
アニオン性高分子増粘剤(E)を含むその他の化粧料成分とを混合する工程(3)を含む製造方法によって、得られることを特徴とする化粧料。 The aqueous dispersion according to claim 1, 2, or 3,
Cosmetics obtained by a production method comprising a step (3) of mixing with other cosmetic ingredients containing an anionic polymer thickener (E).
アニオン性高分子増粘剤(E)を含むその他の化粧料成分とを混合する工程(3)を含む化粧料の製造方法。 The aqueous dispersion according to claim 1, 2, or 3,
The manufacturing method of cosmetics including the process (3) which mixes with other cosmetic ingredients containing an anionic polymer thickener (E).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016018327A JP6802629B2 (en) | 2016-02-02 | 2016-02-02 | Aqueous dispersions, cosmetics and their manufacturing methods |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016018327A JP6802629B2 (en) | 2016-02-02 | 2016-02-02 | Aqueous dispersions, cosmetics and their manufacturing methods |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017137252A true JP2017137252A (en) | 2017-08-10 |
JP6802629B2 JP6802629B2 (en) | 2020-12-16 |
Family
ID=59564594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016018327A Active JP6802629B2 (en) | 2016-02-02 | 2016-02-02 | Aqueous dispersions, cosmetics and their manufacturing methods |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6802629B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114144165A (en) * | 2019-07-31 | 2022-03-04 | 三好化成株式会社 | Preparation method of cosmetic and cosmetic |
WO2023132256A1 (en) | 2022-01-05 | 2023-07-13 | 信越化学工業株式会社 | (poly)glycerin group- and polyoxyalkylene group-containing organopolysiloxane, treated hydrophobic powder, dispersion, and cosmetic |
WO2024214568A1 (en) * | 2023-04-13 | 2024-10-17 | 株式会社 資生堂 | Water-based cosmetic |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011032228A (en) * | 2009-08-04 | 2011-02-17 | Pola Chemical Industries Inc | Cosmetic product for cleansing |
JP2011136965A (en) * | 2009-12-28 | 2011-07-14 | Kao Corp | Oil-in-water type emulsified cosmetic |
JP2011136966A (en) * | 2009-12-28 | 2011-07-14 | Kao Corp | Oil-in-water type emulsified cosmetic |
JP2013053088A (en) * | 2011-09-02 | 2013-03-21 | Pola Chemical Industries Inc | Powder-containing external skin care preparation |
WO2014077174A1 (en) * | 2012-11-14 | 2014-05-22 | 花王株式会社 | Oil-in-water emulsion composition |
JP2015091894A (en) * | 2009-11-06 | 2015-05-14 | 花王株式会社 | Emulsified cosmetics |
-
2016
- 2016-02-02 JP JP2016018327A patent/JP6802629B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011032228A (en) * | 2009-08-04 | 2011-02-17 | Pola Chemical Industries Inc | Cosmetic product for cleansing |
JP2015091894A (en) * | 2009-11-06 | 2015-05-14 | 花王株式会社 | Emulsified cosmetics |
JP2011136965A (en) * | 2009-12-28 | 2011-07-14 | Kao Corp | Oil-in-water type emulsified cosmetic |
JP2011136966A (en) * | 2009-12-28 | 2011-07-14 | Kao Corp | Oil-in-water type emulsified cosmetic |
JP2013053088A (en) * | 2011-09-02 | 2013-03-21 | Pola Chemical Industries Inc | Powder-containing external skin care preparation |
WO2014077174A1 (en) * | 2012-11-14 | 2014-05-22 | 花王株式会社 | Oil-in-water emulsion composition |
JP2014114274A (en) * | 2012-11-14 | 2014-06-26 | Kao Corp | Oil-in-water type emulsified composition |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114144165A (en) * | 2019-07-31 | 2022-03-04 | 三好化成株式会社 | Preparation method of cosmetic and cosmetic |
WO2023132256A1 (en) | 2022-01-05 | 2023-07-13 | 信越化学工業株式会社 | (poly)glycerin group- and polyoxyalkylene group-containing organopolysiloxane, treated hydrophobic powder, dispersion, and cosmetic |
KR20240133731A (en) | 2022-01-05 | 2024-09-04 | 신에쓰 가가꾸 고교 가부시끼가이샤 | Organopolysiloxane having (poly)glycerin group and polyoxyalkylene group, and treated hydrophobic powder, and dispersion and cosmetic |
WO2024214568A1 (en) * | 2023-04-13 | 2024-10-17 | 株式会社 資生堂 | Water-based cosmetic |
Also Published As
Publication number | Publication date |
---|---|
JP6802629B2 (en) | 2020-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6627833B2 (en) | Water dispersion | |
JP5929920B2 (en) | Surface-treated zinc oxide powder, antibacterial agent and antibacterial composition | |
JP6535329B2 (en) | Oil-in-water emulsion composition | |
JP7404651B2 (en) | Oil-in-water emulsion cosmetic and method for producing the same | |
JPWO2012036082A1 (en) | Zinc oxide particles and cosmetics | |
JP4046313B2 (en) | Water-in-oil emulsified composition and emulsified cosmetic using the same | |
JP7695502B2 (en) | Zinc oxide particle dispersion and cosmetic preparation containing same | |
JPWO2008099467A1 (en) | Flaky particles and cosmetics | |
JP5983086B2 (en) | Cosmetics | |
JP6802629B2 (en) | Aqueous dispersions, cosmetics and their manufacturing methods | |
JP6291732B2 (en) | Method for producing composite powder dispersion | |
WO2016121761A1 (en) | Dispersion, production method therefor, and cosmetic | |
JP6051759B2 (en) | Method for producing titanium oxide particles for cosmetics | |
JP6051776B2 (en) | Rare earth doped barium sulfate and cosmetics | |
JP7052317B2 (en) | Underwater oil type sunscreen cosmetics and their manufacturing methods | |
JP2012240995A (en) | Zinc oxide dispersion and cosmetic | |
JP7695503B2 (en) | Titanium dioxide particle dispersion and cosmetic preparation containing same | |
JP2004339326A (en) | Viscous liquid composition, method for producing the same and cosmetic | |
JP2023147613A (en) | Aqueous dispersion and cosmetic | |
WO2022220047A1 (en) | Oil-in-water emulsion cosmetic composition | |
JP2014201465A (en) | Zinc oxide particle, dispersion and cosmetic | |
WO2016121760A1 (en) | Dispersion | |
JP2007045800A (en) | Flaky particle and cosmetic | |
KR20250109189A (en) | Aqueous dispersion of surface-hydrophobic inorganic powder and cosmetics containing the same | |
WO2024106207A1 (en) | Aqueous dispersion of surface-hydrophobized inorganic powder and cosmetic preparation containing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160304 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20181220 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190911 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191001 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20191121 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200129 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20200602 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200901 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20200901 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20200929 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20201006 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201117 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201127 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6802629 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |